Background  	Background  	 NNP	B-NP
Atherosclerosis  	Atherosclerosis  	 NNP	I-NP
and  	and  	 CC	O
coronary  	coronary  	 JJ	B-NP
heart  	heart  	 NN	I-NP
disease  	disease  	 NN	I-NP
( 	( 	 -LRB-	O
CHD 	CHD 	 NNP	B-NP
)  	)  	 -RRB-	O
have  	have  	 VBP	O
long  	long  	 RB	O
been  	been  	 VBN	O
considered  	considered  	 VBN	O
major  	major  	 JJ	O
contributors  	contributors  	 NNS	B-NP
to  	to  	 TO	O
morbidity  	morbidity  	 VB	O
and  	and  	 CC	O
mortality  	mortality  	 NN	O
in  	in  	 IN	O
developed  	developed  	 JJ	O
countries  	countries  	 NNS	O
[  	[  	 -LRB-	O
1 	1 	 CD	O
,  	,  	 ,	O
2 	2 	 CD	O
,  	,  	 ,	O
3 	3 	 LS	O
] 	] 	 -RRB-	O
.  	.  	 .	O
One  	One  	 PRP	O
noted  	noted  	 VBD	B-NP
exception  	exception  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
low  	low  	 JJ	O
mortality  	mortality  	 NN	O
of  	of  	 IN	O
CHD  	CHD  	 NNP	B-NP
in  	in  	 IN	O
France 	France 	 NNP	O
,  	,  	 ,	O
particularly  	particularly  	 RB	O
the  	the  	 DT	O
southwest  	southwest  	 JJS	O
region  	region  	 NN	O
[  	[  	 -LRB-	O
4 	4 	 CD	O
,  	,  	 ,	O
5 	5 	 CD	O
,  	,  	 ,	O
6 	6 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
phenomenon 	phenomenon 	 NN	O
,  	,  	 ,	O
commonly  	commonly  	 RB	O
referred  	referred  	 VBN	O
to  	to  	 TO	O
as  	as  	 IN	O
the  	the  	 DT	O
French  	French  	 JJ	O
paradox 	paradox 	 NN	B-NP
,  	,  	 ,	O
may  	may  	 MD	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
high  	high  	 JJ	O
consumption  	consumption  	 NN	O
of  	of  	 IN	O
red  	red  	 JJ	O
wine  	wine  	 NN	O
[  	[  	 -LRB-	O
7 	7 	 CD	O
,  	,  	 ,	O
8 	8 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
negative  	negative  	 JJ	B-NP
correlation  	correlation  	 NN	I-NP
between  	between  	 IN	O
CHD  	CHD  	 NNP	B-NP
and  	and  	 CC	O
alcohol  	alcohol  	 NN	B-NP
consumption  	consumption  	 NN	I-NP
was  	was  	 VBD	O
first  	first  	 RB	O
noted  	noted  	 VBD	O
25  	25  	 CD	O
years  	years  	 NNS	O
ago 	ago 	 RB	O
,  	,  	 ,	O
and  	and  	 CC	O
numerous  	numerous  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
since  	since  	 IN	O
have  	have  	 VBP	O
confirmed  	confirmed  	 VBN	O
a  	a  	 DT	O
statistically  	statistically  	 JJ	O
significant  	significant  	 JJ	O
inverse  	inverse  	 JJ	B-NP
relationship  	relationship  	 NN	I-NP
between  	between  	 IN	O
these  	these  	 DT	O
two  	two  	 CD	O
factors  	factors  	 NNS	O
[  	[  	 -LRB-	O
9 	9 	 CD	O
,  	,  	 ,	O
10 	10 	 CD	O
,  	,  	 ,	O
11 	11 	 CD	O
,  	,  	 ,	O
12 	12 	 CD	O
,  	,  	 ,	O
13 	13 	 CD	O
,  	,  	 ,	O
14 	14 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
vivo  	vivo  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
shown  	shown  	 VBN	O
that  	that  	 IN	O
wine  	wine  	 NN	O
consumption 	consumption 	 NN	O
,  	,  	 ,	O
particularly  	particularly  	 RB	O
red  	red  	 JJ	O
wine 	wine 	 NN	O
,  	,  	 ,	O
is  	is  	 VBZ	O
more  	more  	 RBR	O
effective  	effective  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
CHD  	CHD  	 NNP	B-NP
not  	not  	 RB	O
seen  	seen  	 VBN	O
with  	with  	 IN	O
other  	other  	 JJ	O
forms  	forms  	 NNS	O
of  	of  	 IN	O
alcoholic  	alcoholic  	 JJ	O
beverages  	beverages  	 NNS	O
[  	[  	 -LRB-	O
15 	15 	 CD	O
,  	,  	 ,	O
16 	16 	 CD	O
,  	,  	 ,	O
17 	17 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Accordingly 	Accordingly 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
postulated  	postulated  	 NNS	O
that  	that  	 WDT	O
naturally  	naturally  	 RB	O
occurring  	occurring  	 VBG	B-NP
components  	components  	 NNS	I-NP
in  	in  	 IN	O
wine  	wine  	 NN	O
might  	might  	 MD	O
afford  	afford  	 VB	O
or  	or  	 CC	O
contribute  	contribute  	 VB	O
to  	to  	 TO	O
its  	its  	 PRP$	O
enhanced  	enhanced  	 JJ	O
protection  	protection  	 NN	O
against  	against  	 IN	O
CHD  	CHD  	 NNP	B-NP
by  	by  	 IN	O
targeting  	targeting  	 VBG	B-NP
sites  	sites  	 NNS	I-NP
that  	that  	 WDT	O
participate  	participate  	 VBP	O
in  	in  	 IN	O
the  	the  	 DT	O
etiology  	etiology  	 NN	O
of  	of  	 IN	O
CHD 	CHD 	 NNP	B-NP
,  	,  	 ,	O
including  	including  	 VBG	O
soluble  	soluble  	 JJ	B-NP
blood  	blood  	 NN	I-NP
components  	components  	 NNS	I-NP
( 	( 	 -LRB-	O
LDL 	LDL 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
cellular  	cellular  	 JJ	B-NP
blood  	blood  	 NN	I-NP
elements  	elements  	 NNS	I-NP
( 	( 	 -LRB-	O
platelets 	platelets 	 LS	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
or  	or  	 CC	O
the  	the  	 DT	O
vasculature  	vasculature  	 NN	B-NP
itself  	itself  	 PRP	O
( 	( 	 -LRB-	O
endothelium 	endothelium 	 LS	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Siemann  	Siemann  	 NNP	B-NP
and  	and  	 CC	O
Creasy  	Creasy  	 NNP	O
proposed  	proposed  	 VBD	O
that  	that  	 IN	O
trans-resveratrol 	trans-resveratrol 	 NNP	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
tri-hydroxy  	tri-hydroxy  	 JJ	B-NP
stilbene 	stilbene 	 NN	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
red  	red  	 JJ	O
wine  	wine  	 NN	O
exhibits  	exhibits  	 VBZ	O
cardioprotective  	cardioprotective  	 JJ	B-NP
properties  	properties  	 NNS	I-NP
[  	[  	 -LRB-	O
18 	18 	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
can  	can  	 MD	O
inhibit  	inhibit  	 VB	O
LDL  	LDL  	 JJ	B-NP
oxidation  	oxidation  	 NNS	I-NP
[  	[  	 -LRB-	O
19 	19 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
suppress  	suppress  	 JJ	O
smooth  	smooth  	 JJ	O
muscle  	muscle  	 NN	B-NP
proliferation  	proliferation  	 NN	I-NP
[  	[  	 -LRB-	O
20 	20 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
induce  	induce  	 FW	O
nitric  	nitric  	 FW	B-NP
oxide  	oxide  	 FW	I-NP
synthase  	synthase  	 FW	I-NP
expression  	expression  	 FW	I-NP
[  	[  	 -LRB-	O
21 	21 	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
block  	block  	 VB	O
collagen-induced  	collagen-induced  	 JJ	B-NP
aggregation  	aggregation  	 JJ	I-NP
responses  	responses  	 NNS	I-NP
in  	in  	 IN	O
washed  	washed  	 JJ	O
platelets  	platelets  	 NNS	B-NP
[  	[  	 -LRB-	O
22 	22 	 CD	O
,  	,  	 ,	O
23 	23 	 CD	O
,  	,  	 ,	O
24 	24 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
relatively  	relatively  	 RB	O
few  	few  	 JJ	O
studies  	studies  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
performed  	performed  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
resveratrol  	resveratrol  	 NN	B-NP
on  	on  	 IN	O
vascular  	vascular  	 JJ	B-NP
components  	components  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
the  	the  	 DT	O
endothelial  	endothelial  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
are  	are  	 VBP	O
known  	known  	 VBN	O
to  	to  	 TO	O
play  	play  	 VB	O
a  	a  	 DT	O
critical  	critical  	 JJ	B-NP
role  	role  	 NN	I-NP
in  	in  	 IN	O
maintaining  	maintaining  	 VBG	O
the  	the  	 DT	O
integrity  	integrity  	 NN	O
and  	and  	 CC	O
functioning  	functioning  	 VBG	O
of  	of  	 IN	O
the  	the  	 DT	O
vascular  	vascular  	 JJ	B-NP
endothelium 	endothelium 	 NN	I-NP
.  	.  	 .	O
Homeostasis  	Homeostasis  	 NNP	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
vascular  	vascular  	 JJ	I-NP
endothelium 	endothelium 	 NN	I-NP
,  	,  	 ,	O
both  	both  	 DT	O
with  	with  	 IN	O
respect  	respect  	 NN	O
to  	to  	 TO	O
metabolic  	metabolic  	 VB	O
and  	and  	 CC	O
physiologic  	physiologic  	 JJ	B-NP
activities 	activities 	 NNS	I-NP
,  	,  	 ,	O
can  	can  	 MD	O
be  	be  	 VB	O
affected  	affected  	 VBN	O
by  	by  	 IN	O
overall  	overall  	 JJ	O
nutritional  	nutritional  	 JJ	B-NP
status  	status  	 NN	I-NP
and  	and  	 CC	O
by  	by  	 IN	O
specific  	specific  	 JJ	O
ingredients  	ingredients  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
diet  	diet  	 NN	O
[  	[  	 -LRB-	O
25 	25 	 CD	O
,  	,  	 ,	O
26 	26 	 CD	O
,  	,  	 ,	O
27 	27 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
aims  	aims  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
were  	were  	 VBD	O
to  	to  	 TO	O
determine  	determine  	 VB	O
changes  	changes  	 NNS	O
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
resveratrol 	resveratrol 	 NNS	B-NP
: 	: 	 :	O
endothelial  	endothelial  	 JJ	B-NP
cell  	cell  	 NN	I-NP
interaction 	interaction 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
observed  	observed  	 VBD	O
that  	that  	 DT	O
resveratrol  	resveratrol  	 JJ	B-NP
induced  	induced  	 JJ	I-NP
significant  	significant  	 JJ	I-NP
cellular  	cellular  	 JJ	I-NP
and  	and  	 CC	O
biochemical  	biochemical  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
in  	in  	 IN	O
endothelial  	endothelial  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
were  	were  	 VBD	O
accompanied  	accompanied  	 VBN	O
by  	by  	 IN	O
altered  	altered  	 JJ	O
functional  	functional  	 JJ	B-NP
responsiveness  	responsiveness  	 NN	I-NP
to  	to  	 TO	O
conditions  	conditions  	 NNS	O
simulating  	simulating  	 VBP	O
arterial  	arterial  	 JJ	B-NP
flow 	flow 	 NN	I-NP
.  	.  	 .	O
Since  	Since  	 IN	O
previous  	previous  	 JJ	O
studies  	studies  	 NNS	O
have  	have  	 VBP	O
shown  	shown  	 VBN	O
several  	several  	 JJ	O
signaling  	signaling  	 JJ	O
molecule  	molecule  	 NN	B-NP
changes  	changes  	 NNS	I-NP
during  	during  	 IN	O
reorganization  	reorganization  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
endothelial  	endothelial  	 FW	I-NP
cell  	cell  	 FW	I-NP
cytoskeleton  	cytoskeleton  	 FW	I-NP
accompanying  	accompanying  	 FW	O
arterial  	arterial  	 FW	O
shear  	shear  	 FW	O
stress  	stress  	 FW	O
[  	[  	 -LRB-	O
28 	28 	 CD	O
,  	,  	 ,	O
29 	29 	 CD	O
,  	,  	 ,	O
30 	30 	 CD	O
,  	,  	 ,	O
31 	31 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
we  	we  	 PRP	O
evaluated  	evaluated  	 VBD	O
the  	the  	 DT	O
same  	same  	 JJ	O
set  	set  	 NN	O
of  	of  	 IN	O
biochemical  	biochemical  	 JJ	B-NP
parameters  	parameters  	 NNS	I-NP
in  	in  	 IN	O
resveratrol-treated  	resveratrol-treated  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
Use  	Use  	 NN	O
of  	of  	 IN	O
selective  	selective  	 JJ	B-NP
signaling  	signaling  	 JJ	I-NP
pathway  	pathway  	 NNS	I-NP
inhibitors  	inhibitors  	 VBP	I-NP
allowed  	allowed  	 VBN	O
the  	the  	 DT	O
demonstration  	demonstration  	 NN	B-NP
that  	that  	 IN	O
the  	the  	 DT	O
cytoskeletal  	cytoskeletal  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
elicited  	elicited  	 VBN	O
by  	by  	 IN	O
resveratrol  	resveratrol  	 JJ	B-NP
depended  	depended  	 NN	I-NP
on  	on  	 IN	O
intracellular  	intracellular  	 JJ	B-NP
calcium  	calcium  	 NN	I-NP
and  	and  	 CC	O
tyrosine  	tyrosine  	 JJ	B-NP
kinase  	kinase  	 JJ	I-NP
activity  	activity  	 NN	I-NP
changes 	changes 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
also  	also  	 RB	O
appeared  	appeared  	 VBD	O
to  	to  	 TO	O
be  	be  	 VB	O
linked  	linked  	 VBN	O
to  	to  	 TO	O
integrity  	integrity  	 NN	O
of  	of  	 IN	O
actin  	actin  	 JJ	B-NP
microfilaments  	microfilaments  	 NN	I-NP
and  	and  	 CC	O
microtubule  	microtubule  	 JJ	B-NP
network 	network 	 NN	I-NP
.  	.  	 .	O
Resveratrol  	Resveratrol  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
also  	also  	 RB	O
led  	led  	 VBN	O
to  	to  	 TO	O
activation  	activation  	 VB	O
of  	of  	 IN	O
ERK1 	ERK1 	 CD	B-NP
/ 	/ 	 CD	O
2  	2  	 CD	O
MAP  	MAP  	 JJ	B-NP
kinase 	kinase 	 NN	I-NP
,  	,  	 ,	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
changes  	changes  	 NNS	O
induced  	induced  	 VBN	O
by  	by  	 IN	O
shear  	shear  	 NNS	O
[  	[  	 -LRB-	O
30 	30 	 CD	O
,  	,  	 ,	O
31 	31 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Thus  	Thus  	 RB	O
resveratrol  	resveratrol  	 RB	O
may  	may  	 MD	O
act  	act  	 VB	O
by  	by  	 IN	O
a  	a  	 DT	O
mechanism 	mechanism 	 NN	B-NP
( 	( 	 -LRB-	I-NP
s 	s 	 LS	I-NP
)  	)  	 -RRB-	I-NP
closely  	closely  	 RB	O
resembling  	resembling  	 VBG	O
that  	that  	 IN	O
triggered  	triggered  	 VBN	O
by  	by  	 IN	O
shear  	shear  	 JJ	O
stress 	stress 	 NN	O
.  	.  	 .	O
Results  	Results  	 NNP	O
Resveratrol  	Resveratrol  	 NNP	B-NP
induces  	induces  	 VBZ	O
morphologic  	morphologic  	 JJ	B-NP
change  	change  	 NN	I-NP
in  	in  	 IN	O
endothelial  	endothelial  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
Sterilized  	Sterilized  	 JJ	O
plastic  	plastic  	 NN	O
18  	18  	 CD	O
mm  	mm  	 CD	O
×  	×  	 CD	O
21  	21  	 CD	O
mm  	mm  	 CD	B-NP
coverslips  	coverslips  	 NNS	I-NP
were  	were  	 VBD	O
seeded  	seeded  	 VBN	O
with  	with  	 IN	O
BPAEC  	BPAEC  	 NNP	B-NP
and  	and  	 CC	O
treated  	treated  	 VBD	O
24  	24  	 CD	O
h  	h  	 NNS	O
later  	later  	 RB	O
with  	with  	 IN	O
various  	various  	 JJ	O
concentrations  	concentrations  	 NNS	B-NP
of  	of  	 IN	I-NP
resveratrol 	resveratrol 	 NN	I-NP
.  	.  	 .	O
Following  	Following  	 VBG	O
an  	an  	 DT	O
additional  	additional  	 JJ	O
2  	2  	 CD	O
day  	day  	 NN	O
of  	of  	 IN	O
culture 	culture 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
coverslips  	coverslips  	 NN	B-NP
containing  	containing  	 VBG	O
the  	the  	 DT	O
attached  	attached  	 JJ	O
BPAECs  	BPAECs  	 NN	B-NP
were  	were  	 VBD	O
fixed 	fixed 	 VBN	O
,  	,  	 ,	O
stained  	stained  	 VBG	O
with  	with  	 IN	O
rhodamine-phalloidin 	rhodamine-phalloidin 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
mounted  	mounted  	 VBN	O
onto  	onto  	 IN	O
slides  	slides  	 NNS	O
for  	for  	 IN	O
analysis  	analysis  	 NN	O
by  	by  	 IN	O
confocal  	confocal  	 JJ	B-NP
microscopy 	microscopy 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
polyphenol  	polyphenol  	 NN	B-NP
( 	( 	 -LRB-	O
100  	100  	 CD	O
μM 	μM 	 NN	B-NP
)  	)  	 -RRB-	O
had  	had  	 VBD	O
a  	a  	 DT	O
distinct  	distinct  	 JJ	O
morphologic  	morphologic  	 JJ	B-NP
effect 	effect 	 NN	I-NP
,  	,  	 ,	O
changing  	changing  	 VBG	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
from  	from  	 IN	O
a  	a  	 DT	O
boxy 	boxy 	 JJ	O
,  	,  	 ,	O
cobblestone-like  	cobblestone-like  	 JJ	B-NP
appearance  	appearance  	 NN	I-NP
( 	( 	 -LRB-	O
panel  	panel  	 NN	O
A 	A 	 NN	O
,  	,  	 ,	O
Fig.  	Fig.  	 CD	O
1 	1 	 CD	O
)  	)  	 -RRB-	O
to  	to  	 TO	O
an  	an  	 DT	O
elongated 	elongated 	 NN	O
,  	,  	 ,	O
ellipsoidal  	ellipsoidal  	 JJ	B-NP
shape  	shape  	 NN	I-NP
with  	with  	 IN	O
long 	long 	 JJ	O
,  	,  	 ,	O
tortuous  	tortuous  	 JJ	B-NP
processes  	processes  	 NNS	I-NP
( 	( 	 -LRB-	O
panel  	panel  	 NN	B-NP
B 	B 	 NNP	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
As  	As  	 IN	O
little  	little  	 JJ	O
as  	as  	 IN	O
25  	25  	 CD	O
μM  	μM  	 JJ	B-NP
resveratrol  	resveratrol  	 NN	I-NP
sufficed  	sufficed  	 VBD	O
to  	to  	 TO	O
induce  	induce  	 VB	O
these  	these  	 DT	O
cellular  	cellular  	 JJ	B-NP
changes 	changes 	 NNS	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
passage  	passage  	 NN	O
4-7  	4-7  	 CD	O
cells  	cells  	 NNS	O
( 	( 	 -LRB-	O
compare  	compare  	 VB	O
panel  	panel  	 NN	O
C  	C  	 NNP	O
with  	with  	 IN	O
panel  	panel  	 NN	O
A 	A 	 NN	O
,  	,  	 ,	O
Fig.  	Fig.  	 CD	O
2 	2 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
To  	To  	 TO	O
quantify  	quantify  	 VB	O
the  	the  	 DT	O
percentages  	percentages  	 NNS	O
of  	of  	 IN	O
cells  	cells  	 NNS	O
with  	with  	 IN	O
the  	the  	 DT	O
elongated  	elongated  	 JJ	O
morphology 	morphology 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
minimum  	minimum  	 NN	O
of  	of  	 IN	O
300  	300  	 CD	O
cells  	cells  	 NNS	O
in  	in  	 IN	O
representative  	representative  	 JJ	B-NP
microscopic  	microscopic  	 JJ	I-NP
field  	field  	 NN	I-NP
were  	were  	 VBD	O
counted  	counted  	 VBN	O
and  	and  	 CC	O
the  	the  	 DT	O
results  	results  	 NNS	O
presented  	presented  	 VBN	O
in  	in  	 IN	O
Fig.  	Fig.  	 CD	O
3 	3 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
cells  	cells  	 NNS	O
showing  	showing  	 VBG	O
the  	the  	 DT	O
elongated  	elongated  	 JJ	O
phenotype  	phenotype  	 NN	B-NP
is  	is  	 VBZ	O
proportional  	proportional  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	I-NP
resveratrol  	resveratrol  	 NN	I-NP
added  	added  	 VBD	O
to  	to  	 TO	O
the  	the  	 DT	O
culture 	culture 	 NN	O
.  	.  	 .	O
Treatment  	Treatment  	 NN	O
with  	with  	 IN	O
resveratrol  	resveratrol  	 VBG	O
also  	also  	 RB	O
suppressed  	suppressed  	 JJ	O
growth  	growth  	 NN	O
of  	of  	 IN	O
BPAEC  	BPAEC  	 NNP	O
( 	( 	 -LRB-	O
data  	data  	 NNS	O
not  	not  	 RB	O
shown 	shown 	 VBN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
as  	as  	 IN	O
we  	we  	 PRP	O
previously  	previously  	 RB	O
reported  	reported  	 VBD	O
[  	[  	 -LRB-	O
21 	21 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Resveratrol  	Resveratrol  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
leads  	leads  	 VBZ	O
to  	to  	 TO	O
increased  	increased  	 JJ	O
adherence  	adherence  	 NN	O
of  	of  	 IN	O
BPAEC  	BPAEC  	 NNP	B-NP
under  	under  	 IN	O
simulated  	simulated  	 JJ	O
arterial  	arterial  	 JJ	B-NP
flow  	flow  	 NN	I-NP
conditions  	conditions  	 NNS	I-NP
To  	To  	 TO	O
test  	test  	 VB	O
whether  	whether  	 IN	O
functional  	functional  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
may  	may  	 MD	O
accompany  	accompany  	 VB	O
the  	the  	 DT	O
modified  	modified  	 JJ	O
morphology 	morphology 	 NN	O
,  	,  	 ,	O
control  	control  	 NN	O
and  	and  	 CC	O
2  	2  	 CD	O
day  	day  	 NN	O
and  	and  	 CC	O
100  	100  	 CD	O
μM  	μM  	 JJ	B-NP
resveratrol-treated  	resveratrol-treated  	 JJ	I-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
0  	0  	 CD	O
min  	min  	 NNS	B-NP
( 	( 	 -LRB-	O
control 	control 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
2  	2  	 CD	O
min 	min 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
5  	5  	 CD	O
min  	min  	 NN	B-NP
of  	of  	 IN	O
simulated  	simulated  	 JJ	O
arterial  	arterial  	 JJ	O
shear  	shear  	 NNS	O
stress  	stress  	 VBP	O
using  	using  	 VBG	O
a  	a  	 DT	O
parallel  	parallel  	 JJ	B-NP
plate  	plate  	 NN	I-NP
perfusion  	perfusion  	 NN	I-NP
chamber  	chamber  	 NN	I-NP
( 	( 	 -LRB-	O
see  	see  	 VB	O
Materials  	Materials  	 NNPS	O
and  	and  	 CC	O
Methods 	Methods 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Following  	Following  	 VBG	O
the  	the  	 DT	O
shear  	shear  	 JJ	O
challenge 	challenge 	 NN	O
,  	,  	 ,	O
cells  	cells  	 NNS	O
remaining  	remaining  	 VBG	O
attached  	attached  	 VBN	O
were  	were  	 VBD	O
scored  	scored  	 VBN	O
by  	by  	 IN	O
staining  	staining  	 NN	O
with  	with  	 IN	O
rhodamine-phalloidin 	rhodamine-phalloidin 	 NNP	B-NP
,  	,  	 ,	O
as  	as  	 RB	O
described 	described 	 VBN	O
.  	.  	 .	O
Since  	Since  	 IN	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
evenly  	evenly  	 RB	O
distributed  	distributed  	 VBN	O
throughout  	throughout  	 IN	O
the  	the  	 DT	O
area  	area  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
coverslip  	coverslip  	 NN	B-NP
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
flow 	flow 	 VB	O
,  	,  	 ,	O
representative  	representative  	 JJ	B-NP
pictures  	pictures  	 NNS	I-NP
were  	were  	 VBD	O
taken  	taken  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
confocal  	confocal  	 JJ	B-NP
microscopy  	microscopy  	 JJ	I-NP
fields  	fields  	 NNS	I-NP
located  	located  	 VBN	O
directly  	directly  	 RB	O
in  	in  	 IN	O
the  	the  	 DT	O
center  	center  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
coverslip 	coverslip 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
counted 	counted 	 VBN	O
.  	.  	 .	O
As  	As  	 RB	O
can  	can  	 MD	O
be  	be  	 VB	O
seen  	seen  	 VBN	O
in  	in  	 IN	O
Fig.  	Fig.  	 CD	O
4 	4 	 CD	O
,  	,  	 ,	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
0  	0  	 CD	O
min  	min  	 JJ	B-NP
sample 	sample 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
resveratrol-treated  	resveratrol-treated  	 NNP	B-NP
BPAEC  	BPAEC  	 NNP	I-NP
remained  	remained  	 VBD	O
attached  	attached  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
plastic  	plastic  	 JJ	B-NP
coverslips  	coverslips  	 NN	I-NP
after  	after  	 IN	O
2  	2  	 CD	O
min  	min  	 NNS	B-NP
and  	and  	 CC	O
5  	5  	 CD	O
min  	min  	 JJ	B-NP
flow  	flow  	 NN	I-NP
challenge 	challenge 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
comparison 	comparison 	 NN	O
,  	,  	 ,	O
under  	under  	 IN	O
identical  	identical  	 JJ	O
experimental  	experimental  	 JJ	B-NP
conditions 	conditions 	 NNS	I-NP
,  	,  	 ,	O
cells  	cells  	 NNS	O
adhering  	adhering  	 VBP	O
to  	to  	 TO	O
the  	the  	 DT	O
coverslips  	coverslips  	 NN	B-NP
decreased  	decreased  	 VBD	O
dramatically  	dramatically  	 RB	O
in  	in  	 IN	O
controls 	controls 	 NNS	O
,  	,  	 ,	O
with  	with  	 IN	O
virtually  	virtually  	 RB	O
no  	no  	 DT	O
cells  	cells  	 NNS	O
remaining  	remaining  	 VBG	O
after  	after  	 IN	O
a  	a  	 DT	O
5  	5  	 CD	O
min  	min  	 CD	B-NP
simulated  	simulated  	 JJ	O
flow 	flow 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
a  	a  	 DT	O
functional  	functional  	 JJ	B-NP
alteration 	alteration 	 NN	I-NP
,  	,  	 ,	O
measured  	measured  	 VBN	O
by  	by  	 IN	O
greater  	greater  	 JJR	O
adherence  	adherence  	 NN	O
of  	of  	 IN	O
cells  	cells  	 NNS	O
under  	under  	 IN	O
simulated  	simulated  	 JJ	O
arterial  	arterial  	 JJ	B-NP
flow  	flow  	 NN	I-NP
conditions 	conditions 	 NNS	I-NP
,  	,  	 ,	O
accompanied  	accompanied  	 VBN	O
the  	the  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
cellular  	cellular  	 JJ	B-NP
phenotype 	phenotype 	 NN	I-NP
,  	,  	 ,	O
following  	following  	 VBG	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
resveratrol 	resveratrol 	 NN	B-NP
.  	.  	 .	O
Effect  	Effect  	 NN	O
of  	of  	 IN	O
cell  	cell  	 NN	O
signaling  	signaling  	 VBG	B-NP
inhibitors  	inhibitors  	 NN	I-NP
on  	on  	 IN	O
cell  	cell  	 NN	O
elongation  	elongation  	 VBZ	O
induced  	induced  	 VBN	O
by  	by  	 IN	O
resveratrol  	resveratrol  	 JJ	B-NP
Further  	Further  	 JJ	I-NP
insights  	insights  	 NNS	I-NP
into  	into  	 IN	O
the  	the  	 DT	O
nature  	nature  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
resveratrol-induced  	resveratrol-induced  	 JJ	B-NP
morphologcial  	morphologcial  	 JJ	I-NP
changes  	changes  	 NNS	I-NP
came  	came  	 VBD	O
from  	from  	 IN	O
studies  	studies  	 NNS	O
using  	using  	 VBG	O
selective  	selective  	 JJ	B-NP
inhibitors  	inhibitors  	 NN	I-NP
for  	for  	 IN	O
different  	different  	 JJ	O
signaling  	signaling  	 JJ	O
pathways 	pathways 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
include 	include 	 VBP	O
:  	:  	 :	O
quin2-AM  	quin2-AM  	 CD	B-NP
( 	( 	 -LRB-	O
intracellular  	intracellular  	 FW	B-NP
[ 	[ 	 -LRB-	O
Ca  	Ca  	 NNP	B-NP
2+ 	2+ 	 NNP	O
] 	] 	 -RRB-	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
herbimycin  	herbimycin  	 VBG	O
A  	A  	 DT	O
( 	( 	 -LRB-	O
tyrosine  	tyrosine  	 FW	B-NP
kinases 	kinases 	 FW	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
chelerythrine  	chelerythrine  	 NNS	B-NP
( 	( 	 -LRB-	O
PKC 	PKC 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
cytochalasin  	cytochalasin  	 VBG	O
D  	D  	 NNP	O
( 	( 	 -LRB-	O
actin  	actin  	 FW	B-NP
microfilaments 	microfilaments 	 FW	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
nocodazole  	nocodazole  	 NNS	B-NP
( 	( 	 -LRB-	O
disassembly  	disassembly  	 NN	O
of  	of  	 IN	O
microtubules 	microtubules 	 CD	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
inhibitors 	inhibitors 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
concentrations  	concentrations  	 NNS	B-NP
indicated  	indicated  	 VBD	O
in  	in  	 IN	O
Materials  	Materials  	 NNPS	O
and  	and  	 CC	O
Methods 	Methods 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
then  	then  	 RB	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
resveratrol 	resveratrol 	 VB	O
.  	.  	 .	O
Representative  	Representative  	 NNP	B-NP
confocal  	confocal  	 VBD	O
microscopy  	microscopy  	 JJ	O
fields  	fields  	 NNS	O
for  	for  	 IN	O
both  	both  	 DT	O
control  	control  	 NN	O
and  	and  	 CC	O
resveratrol-treated  	resveratrol-treated  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
counted  	counted  	 VBN	O
for  	for  	 IN	O
elongated  	elongated  	 NN	O
and  	and  	 CC	O
non-elongated  	non-elongated  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
inhibitors  	inhibitors  	 NN	O
used  	used  	 VBD	O
noticeably  	noticeably  	 RB	O
suppressed  	suppressed  	 JJ	O
cell  	cell  	 NN	B-NP
growth  	growth  	 NN	I-NP
( 	( 	 -LRB-	O
particularly  	particularly  	 RB	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
cytochalasin  	cytochalasin  	 JJ	O
D  	D  	 NNP	O
and  	and  	 CC	O
nocodazole 	nocodazole 	 CD	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
particularly  	particularly  	 RB	O
controls  	controls  	 VBZ	O
not  	not  	 RB	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
resveratrol 	resveratrol 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
degree  	degree  	 NN	O
of  	of  	 IN	O
growth  	growth  	 NN	B-NP
inhibition  	inhibition  	 VBZ	I-NP
varied 	varied 	 VBN	O
,  	,  	 ,	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
preparations  	preparations  	 NNS	B-NP
of  	of  	 IN	I-NP
primary  	primary  	 JJ	I-NP
BPAEC 	BPAEC 	 NNP	I-NP
.  	.  	 .	O
Interestingly 	Interestingly 	 RB	O
,  	,  	 ,	O
cells  	cells  	 NNS	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
resveratrol 	resveratrol 	 NN	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
had  	had  	 VBD	O
to  	to  	 TO	O
be  	be  	 VB	O
reduced  	reduced  	 VBN	O
to  	to  	 TO	O
40  	40  	 CD	O
h  	h  	 NN	O
because  	because  	 IN	O
of  	of  	 IN	O
adverse  	adverse  	 JJ	O
responses  	responses  	 NNS	O
of  	of  	 IN	O
control  	control  	 NN	B-NP
cells  	cells  	 NNS	I-NP
to  	to  	 TO	O
inhibitors  	inhibitors  	 VB	O
( 	( 	 -LRB-	O
see  	see  	 VB	O
Materials  	Materials  	 NNPS	O
and  	and  	 CC	O
Methods 	Methods 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
afforded  	afforded  	 VBN	O
better  	better  	 JJR	O
growth  	growth  	 NN	B-NP
in  	in  	 IN	O
samples  	samples  	 NNS	O
containing  	containing  	 VBG	O
the  	the  	 DT	O
inhibitors 	inhibitors 	 NN	O
.  	.  	 .	O
Table  	Table  	 NN	O
1summarized  	1summarized  	 CD	O
results  	results  	 NNS	O
averaged  	averaged  	 VBD	O
from  	from  	 IN	O
4  	4  	 CD	O
separate  	separate  	 JJ	O
experiments 	experiments 	 NNS	O
,  	,  	 ,	O
each  	each  	 DT	O
performed  	performed  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
different  	different  	 JJ	O
preparation  	preparation  	 NN	B-NP
of  	of  	 IN	I-NP
primary  	primary  	 JJ	I-NP
BPAEC 	BPAEC 	 NNP	I-NP
.  	.  	 .	O
Since  	Since  	 IN	O
growth  	growth  	 NN	B-NP
of  	of  	 IN	I-NP
control  	control  	 NN	I-NP
cells  	cells  	 NNS	I-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
their  	their  	 PRP$	O
response  	response  	 NN	O
to  	to  	 TO	O
resveratrol  	resveratrol  	 VB	O
and  	and  	 CC	O
addition  	addition  	 NN	B-NP
of  	of  	 IN	O
inhibitors  	inhibitors  	 JJ	O
differed  	differed  	 NN	O
between  	between  	 IN	O
BPAEC  	BPAEC  	 NNP	B-NP
preparations 	preparations 	 NNS	I-NP
,  	,  	 ,	O
cells  	cells  	 NNS	O
showing  	showing  	 VBG	O
the  	the  	 DT	O
elongated  	elongated  	 JJ	O
shape  	shape  	 NN	O
in  	in  	 IN	O
each  	each  	 DT	O
experiment  	experiment  	 NN	O
were  	were  	 VBD	O
calculated  	calculated  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
percent  	percent  	 NN	O
of  	of  	 IN	O
total  	total  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
counted  	counted  	 VBN	O
( 	( 	 -LRB-	O
ranging  	ranging  	 VBG	O
from  	from  	 IN	O
60-700 	60-700 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
numbers  	numbers  	 NNS	O
obtained  	obtained  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
manner  	manner  	 NN	O
were  	were  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
calculate  	calculate  	 VB	O
the  	the  	 DT	O
mean  	mean  	 NN	B-NP
( 	( 	 -LRB-	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
±  	±  	 NNP	O
SD 	SD 	 NNP	B-NP
,  	,  	 ,	O
as  	as  	 RB	O
shown 	shown 	 VBN	O
.  	.  	 .	O
Addition  	Addition  	 NN	B-NP
of  	of  	 IN	I-NP
chelerythrine 	chelerythrine 	 NN	I-NP
,  	,  	 ,	O
an  	an  	 DT	O
inhibitor  	inhibitor  	 NN	O
of  	of  	 IN	O
protein  	protein  	 NN	B-NP
kinase  	kinase  	 VBD	O
C 	C 	 NNP	O
,  	,  	 ,	O
caused  	caused  	 VBD	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
elongated  	elongated  	 JJ	O
cells  	cells  	 NNS	O
alone  	alone  	 RB	O
and  	and  	 CC	O
did  	did  	 VBD	O
not  	not  	 RB	O
affect  	affect  	 VB	O
morphologic  	morphologic  	 JJ	B-NP
response  	response  	 NN	I-NP
of  	of  	 IN	O
cells  	cells  	 NNS	O
to  	to  	 TO	O
resveratrol 	resveratrol 	 VB	O
.  	.  	 .	O
Inhibitors  	Inhibitors  	 NNP	O
of  	of  	 IN	O
intracellular  	intracellular  	 NNS	B-NP
[ 	[ 	 -LRB-	O
Ca  	Ca  	 NNP	B-NP
2+ 	2+ 	 NNP	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
tyrosine  	tyrosine  	 JJ	B-NP
kinase  	kinase  	 JJ	I-NP
activity  	activity  	 NN	I-NP
effectively  	effectively  	 RB	O
reduced  	reduced  	 VBN	O
the  	the  	 DT	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
elongated  	elongated  	 JJ	O
cells  	cells  	 NNS	O
elicited  	elicited  	 VBN	O
by  	by  	 IN	O
resveratrol 	resveratrol 	 NN	B-NP
.  	.  	 .	O
Results  	Results  	 NNS	O
in  	in  	 IN	O
Table  	Table  	 NNP	O
1further  	1further  	 NNP	O
showed  	showed  	 VBD	O
that  	that  	 DT	O
cytoskeletal  	cytoskeletal  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
elicited  	elicited  	 VBN	O
by  	by  	 IN	O
resveratrol  	resveratrol  	 VBG	O
also  	also  	 RB	O
appeared  	appeared  	 VBD	O
to  	to  	 TO	O
be  	be  	 VB	O
linked  	linked  	 VBN	O
to  	to  	 TO	O
integrity  	integrity  	 NN	O
of  	of  	 IN	O
actin  	actin  	 JJ	B-NP
microfilaments  	microfilaments  	 NN	I-NP
and  	and  	 CC	O
microtubule  	microtubule  	 JJ	B-NP
network  	network  	 NN	I-NP
as  	as  	 IN	O
the  	the  	 DT	O
morphologic  	morphologic  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
were  	were  	 VBD	O
also  	also  	 RB	O
substantially  	substantially  	 RB	O
lowered  	lowered  	 VBN	O
in  	in  	 IN	O
cells  	cells  	 NNS	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
cytochalasin  	cytochalasin  	 JJ	O
D  	D  	 NNP	O
and  	and  	 CC	O
nocodazole 	nocodazole 	 NN	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
inhibit  	inhibit  	 VBP	O
formation  	formation  	 NN	O
of  	of  	 IN	O
actin  	actin  	 JJ	B-NP
microfilaments  	microfilaments  	 NN	I-NP
and  	and  	 CC	O
microtubule  	microtubule  	 JJ	B-NP
network 	network 	 NN	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
Effect  	Effect  	 NN	O
of  	of  	 IN	O
resveratrol  	resveratrol  	 NN	B-NP
on  	on  	 IN	O
ERK1 	ERK1 	 CD	B-NP
/ 	/ 	 CD	O
2  	2  	 CD	O
activation  	activation  	 NNS	B-NP
and  	and  	 CC	O
eIF4E 	eIF4E 	 NNP	O
,  	,  	 ,	O
eNOS  	eNOS  	 JJ	B-NP
expression  	expression  	 NN	I-NP
Biochemical  	Biochemical  	 NNP	I-NP
changes  	changes  	 NNS	I-NP
in  	in  	 IN	O
resveratrol-treated  	resveratrol-treated  	 NNP	B-NP
BPAEC  	BPAEC  	 NNP	I-NP
were  	were  	 VBD	O
assessed  	assessed  	 VBN	O
by  	by  	 IN	O
western  	western  	 JJ	O
blot  	blot  	 JJ	O
analyses 	analyses 	 NNS	O
.  	.  	 .	O
Fig.  	Fig.  	 NNP	O
5shows  	5shows  	 NNP	O
that  	that  	 IN	O
in  	in  	 IN	O
control  	control  	 NN	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
level  	level  	 NN	O
of  	of  	 IN	O
active  	active  	 JJ	O
ERK1 	ERK1 	 NNP	B-NP
/ 	/ 	 NNP	O
2-P  	2-P  	 NNP	B-NP
remained  	remained  	 VBD	O
relatively  	relatively  	 RB	O
constant  	constant  	 VB	O
up  	up  	 RP	O
to  	to  	 TO	O
48  	48  	 CD	O
h  	h  	 NNS	O
but  	but  	 CC	O
showed  	showed  	 VBD	O
a  	a  	 DT	O
precipitous  	precipitous  	 JJ	B-NP
decline  	decline  	 NN	I-NP
from  	from  	 IN	O
48  	48  	 CD	O
to  	to  	 TO	O
96  	96  	 CD	O
h  	h  	 NNS	O
( 	( 	 -LRB-	O
panel  	panel  	 NN	O
A 	A 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Under  	Under  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
conditions 	conditions 	 NNS	O
,  	,  	 ,	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
total  	total  	 JJ	B-NP
ERK1 	ERK1 	 CD	I-NP
/ 	/ 	 CD	O
2  	2  	 CD	O
( 	( 	 -LRB-	O
panel  	panel  	 NN	B-NP
B 	B 	 NNP	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
eIF4E  	eIF4E  	 NNP	O
( 	( 	 -LRB-	O
panel  	panel  	 NN	O
C 	C 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
a  	a  	 DT	O
downstream  	downstream  	 JJ	O
effector  	effector  	 NN	B-NP
of  	of  	 IN	I-NP
ERK1 	ERK1 	 CD	I-NP
/ 	/ 	 CD	O
ERK2 	ERK2 	 CD	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
actin  	actin  	 NNS	B-NP
( 	( 	 -LRB-	O
panel  	panel  	 NN	B-NP
E 	E 	 NN	I-NP
)  	)  	 -RRB-	O
showed  	showed  	 VBD	O
no  	no  	 DT	O
substantial  	substantial  	 JJ	O
change  	change  	 NN	O
at  	at  	 IN	O
all  	all  	 DT	O
time  	time  	 NN	B-NP
points  	points  	 NNS	I-NP
assayed 	assayed 	 NN	O
,  	,  	 ,	O
in  	in  	 IN	O
control  	control  	 NN	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
Treatment  	Treatment  	 NN	O
with  	with  	 IN	O
25  	25  	 CD	O
μM  	μM  	 JJ	O
and  	and  	 CC	O
100  	100  	 CD	O
μM  	μM  	 JJ	B-NP
resveratrol  	resveratrol  	 NN	I-NP
prevented  	prevented  	 VBD	O
the  	the  	 DT	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
active  	active  	 JJ	O
ERK1 	ERK1 	 CD	B-NP
/ 	/ 	 CD	O
2-P  	2-P  	 CD	B-NP
seen  	seen  	 VBN	O
at  	at  	 IN	O
96  	96  	 CD	O
h  	h  	 NNS	O
( 	( 	 -LRB-	O
panel  	panel  	 NN	O
A 	A 	 NN	O
,  	,  	 ,	O
last  	last  	 JJ	O
3  	3  	 CD	O
lanes 	lanes 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
these  	these  	 DT	O
concentrations  	concentrations  	 NNS	B-NP
of  	of  	 IN	O
resveratrol  	resveratrol  	 VBG	O
markedly  	markedly  	 RB	O
increased  	increased  	 VBN	B-NP
eNOS  	eNOS  	 JJ	I-NP
expression  	expression  	 NN	I-NP
as  	as  	 IN	O
early  	early  	 JJ	O
as  	as  	 IN	O
6-h 	6-h 	 NNP	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
reached  	reached  	 VBD	O
maximum  	maximum  	 JJ	B-NP
induction  	induction  	 NN	I-NP
at  	at  	 IN	O
48-h 	48-h 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
remained  	remained  	 VBD	O
substantially  	substantially  	 RB	O
elevated  	elevated  	 VBD	O
at  	at  	 IN	O
96-h  	96-h  	 NNP	O
( 	( 	 -LRB-	O
panel  	panel  	 NN	O
D 	D 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Quantification  	Quantification  	 NNP	B-NP
of  	of  	 IN	I-NP
relative  	relative  	 JJ	I-NP
changes  	changes  	 NNS	I-NP
of  	of  	 IN	I-NP
total  	total  	 JJ	I-NP
ERK1 	ERK1 	 CD	I-NP
/ 	/ 	 CD	O
2 	2 	 CD	O
,  	,  	 ,	O
active  	active  	 JJ	O
ERK1 	ERK1 	 CD	B-NP
/ 	/ 	 CD	O
2-P 	2-P 	 CD	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
eNOS  	eNOS  	 JJ	B-NP
as  	as  	 IN	O
a  	a  	 DT	O
function  	function  	 NN	O
of  	of  	 IN	O
time  	time  	 NN	O
of  	of  	 IN	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
two  	two  	 CD	O
concentrations  	concentrations  	 NNS	B-NP
of  	of  	 IN	I-NP
resveratrol  	resveratrol  	 NN	I-NP
is  	is  	 VBZ	O
depicted  	depicted  	 VBN	O
in  	in  	 IN	O
Figure  	Figure  	 NNP	O
6 	6 	 CD	O
.  	.  	 .	O
Discussion  	Discussion  	 NNP	O
Modulation  	Modulation  	 NNP	B-NP
of  	of  	 IN	I-NP
endothelial  	endothelial  	 JJ	I-NP
cell  	cell  	 NN	I-NP
shape  	shape  	 NN	I-NP
by  	by  	 IN	O
resveratrol  	resveratrol  	 JJ	B-NP
Size 	Size 	 NN	I-NP
,  	,  	 ,	O
shape 	shape 	 NN	O
,  	,  	 ,	O
mutual  	mutual  	 JJ	B-NP
orientation 	orientation 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
intercellular  	intercellular  	 JJ	B-NP
contacts  	contacts  	 NNS	I-NP
in  	in  	 IN	O
endothelium  	endothelium  	 NNS	B-NP
are  	are  	 VBP	O
not  	not  	 RB	O
incidental  	incidental  	 JJ	O
and  	and  	 CC	O
statistic  	statistic  	 JJ	B-NP
events 	events 	 NNS	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
precisely  	precisely  	 RB	O
and  	and  	 CC	O
dynamically  	dynamically  	 VB	O
regulated 	regulated 	 VBN	O
.  	.  	 .	O
Reversible  	Reversible  	 JJ	B-NP
change  	change  	 NN	I-NP
of  	of  	 IN	I-NP
endothelial  	endothelial  	 JJ	I-NP
cell  	cell  	 NN	I-NP
shape 	shape 	 NN	I-NP
,  	,  	 ,	O
mutual  	mutual  	 JJ	B-NP
orientation  	orientation  	 NN	I-NP
of  	of  	 IN	O
cells  	cells  	 NNS	O
in  	in  	 IN	O
certain  	certain  	 JJ	O
directions 	directions 	 NNS	O
,  	,  	 ,	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
intercellular  	intercellular  	 JJ	B-NP
contacts 	contacts 	 NNS	I-NP
,  	,  	 ,	O
are  	are  	 VBP	O
controlled  	controlled  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
factors 	factors 	 NNS	O
,  	,  	 ,	O
such  	such  	 JJ	O
as 	as 	 RB	O
,  	,  	 ,	O
cooperative  	cooperative  	 JJ	B-NP
stimulation  	stimulation  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
receptors  	receptors  	 NN	I-NP
or  	or  	 CC	O
the  	the  	 DT	O
systems  	systems  	 NNS	O
of  	of  	 IN	O
second  	second  	 JJ	O
messengers  	messengers  	 NNS	O
[  	[  	 -LRB-	O
32 	32 	 CD	O
,  	,  	 ,	O
33 	33 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
dietary  	dietary  	 JJ	B-NP
ingredients 	ingredients 	 NNS	I-NP
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
retinoids  	retinoids  	 NNS	B-NP
[  	[  	 -LRB-	O
34 	34 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
exercise  	exercise  	 NN	O
[  	[  	 -LRB-	O
35 	35 	 CD	O
,  	,  	 ,	O
36 	36 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
fluid-imposed  	fluid-imposed  	 JJ	B-NP
shear  	shear  	 JJ	O
stress  	stress  	 NN	O
[  	[  	 -LRB-	O
37 	37 	 CD	O
,  	,  	 ,	O
38 	38 	 CD	O
,  	,  	 ,	O
39 	39 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
endothelial  	endothelial  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
are  	are  	 VBP	O
known  	known  	 VBN	O
to  	to  	 TO	O
elongate  	elongate  	 VB	O
and  	and  	 CC	O
reorient  	reorient  	 VB	O
their  	their  	 PRP$	O
cytoskeletons  	cytoskeletons  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
direction  	direction  	 NN	O
of  	of  	 IN	O
flow  	flow  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
normal  	normal  	 JJ	B-NP
physiological  	physiological  	 JJ	I-NP
response  	response  	 NN	I-NP
to  	to  	 TO	O
prolonged  	prolonged  	 JJ	O
shear  	shear  	 JJ	O
stress  	stress  	 NN	O
[  	[  	 -LRB-	O
29 	29 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Results  	Results  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
studies  	studies  	 NNS	O
show  	show  	 VBP	O
that  	that  	 DT	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
resveratrol  	resveratrol  	 NN	B-NP
induces  	induces  	 VBZ	O
a  	a  	 DT	O
morphologic  	morphologic  	 JJ	B-NP
change  	change  	 NN	I-NP
from  	from  	 IN	O
a  	a  	 DT	O
stellar  	stellar  	 JJ	O
to  	to  	 TO	O
an  	an  	 DT	O
elongated  	elongated  	 JJ	O
shape  	shape  	 NN	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
tempting  	tempting  	 VBN	O
to  	to  	 TO	O
speculate  	speculate  	 VB	O
that  	that  	 DT	O
appearance  	appearance  	 NN	O
of  	of  	 IN	O
such  	such  	 JJ	O
cellular  	cellular  	 JJ	B-NP
phenotype  	phenotype  	 NN	I-NP
involves  	involves  	 VBZ	O
formation  	formation  	 NN	O
of  	of  	 IN	O
stress  	stress  	 NN	B-NP
fibers 	fibers 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
would  	would  	 MD	O
rearrange  	rearrange  	 VB	O
the  	the  	 DT	O
cytoskeleton  	cytoskeleton  	 NN	B-NP
in  	in  	 IN	O
ways  	ways  	 NNS	O
that  	that  	 WDT	O
facilitate  	facilitate  	 VBP	O
better  	better  	 JJR	O
anchoring  	anchoring  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
BPAEC  	BPAEC  	 NNP	B-NP
to  	to  	 TO	O
the  	the  	 DT	O
culture  	culture  	 NN	B-NP
substratum  	substratum  	 NNS	I-NP
and  	and  	 CC	O
contribute  	contribute  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	I-NP
BPAEC  	BPAEC  	 NNP	I-NP
to  	to  	 TO	O
resist  	resist  	 VB	O
simulated  	simulated  	 JJ	O
arterial  	arterial  	 JJ	B-NP
flow  	flow  	 NN	I-NP
challenge 	challenge 	 NN	I-NP
.  	.  	 .	O
Only  	Only  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
future  	future  	 NN	O
would  	would  	 MD	O
validate  	validate  	 VB	O
such  	such  	 PDT	O
a  	a  	 DT	O
possibility 	possibility 	 NN	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
also  	also  	 RB	O
interesting  	interesting  	 JJ	O
to  	to  	 TO	O
note  	note  	 VB	O
that  	that  	 IN	O
the  	the  	 DT	O
observed  	observed  	 JJ	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
resveratrol-treated  	resveratrol-treated  	 JJ	B-NP
BPAEC  	BPAEC  	 NNS	I-NP
are  	are  	 VBP	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
that  	that  	 WDT	O
described  	described  	 VBD	O
for  	for  	 IN	O
EC  	EC  	 NNP	B-NP
subjected  	subjected  	 VBN	O
to  	to  	 TO	O
arterial  	arterial  	 VB	O
shear 	shear 	 NNS	O
.  	.  	 .	O
We  	We  	 PRP	O
propose  	propose  	 VBP	O
that  	that  	 IN	O
this  	this  	 DT	O
could  	could  	 MD	O
represent  	represent  	 VB	O
a  	a  	 DT	O
physiologically-relevant  	physiologically-relevant  	 JJ	O
mechanism  	mechanism  	 NN	O
by  	by  	 IN	O
which  	which  	 WDT	O
resveratrol 	resveratrol 	 VBZ	O
,  	,  	 ,	O
as  	as  	 IN	O
a  	a  	 DT	O
polyphenolic  	polyphenolic  	 JJ	B-NP
constituent  	constituent  	 NN	I-NP
of  	of  	 IN	O
red  	red  	 JJ	O
wine 	wine 	 NN	O
,  	,  	 ,	O
contributes  	contributes  	 VBZ	O
to  	to  	 TO	O
cardioprotection  	cardioprotection  	 VB	O
by  	by  	 IN	O
inducing  	inducing  	 JJ	O
resistance  	resistance  	 NN	O
to  	to  	 TO	O
potential  	potential  	 JJ	B-NP
damage  	damage  	 NN	I-NP
by  	by  	 IN	O
shearing  	shearing  	 JJ	O
forces 	forces 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
mechanism  	mechanism  	 NN	O
underlying  	underlying  	 VBG	O
this  	this  	 DT	O
cytoskeletal  	cytoskeletal  	 JJ	B-NP
rearrangement  	rearrangement  	 JJ	I-NP
due  	due  	 JJ	O
to  	to  	 TO	O
shear  	shear  	 VB	O
stress  	stress  	 NN	O
is  	is  	 VBZ	O
ill-defined 	ill-defined 	 JJ	O
,  	,  	 ,	O
but  	but  	 CC	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
found  	found  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
linked  	linked  	 VBN	O
to  	to  	 TO	O
tyrosine  	tyrosine  	 VB	O
kinase  	kinase  	 JJ	B-NP
activity 	activity 	 NN	I-NP
,  	,  	 ,	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
intracellular  	intracellular  	 JJ	B-NP
calcium 	calcium 	 NN	I-NP
,  	,  	 ,	O
intact  	intact  	 JJ	O
actin  	actin  	 JJ	B-NP
microfilaments 	microfilaments 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
functional  	functional  	 JJ	B-NP
microtubule  	microtubule  	 JJ	I-NP
network 	network 	 NN	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
is  	is  	 VBZ	O
independent  	independent  	 JJ	O
of  	of  	 IN	O
protein  	protein  	 NN	B-NP
kinase  	kinase  	 VBD	O
C 	C 	 NNP	O
,  	,  	 ,	O
intermediate  	intermediate  	 JJ	O
filaments 	filaments 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
stretch-  	stretch-  	 JJ	O
and  	and  	 CC	O
shear-activated  	shear-activated  	 JJ	O
mechanosensitive  	mechanosensitive  	 JJ	B-NP
K  	K  	 NNP	I-NP
+channels  	+channels  	 NNP	O
[  	[  	 -LRB-	O
28 	28 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
therefore  	therefore  	 RB	O
sought  	sought  	 VBN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
whether  	whether  	 IN	O
a  	a  	 DT	O
similar  	similar  	 JJ	O
mechanism  	mechanism  	 NN	O
could  	could  	 MD	O
account  	account  	 VB	O
for  	for  	 IN	O
the  	the  	 DT	O
resveratrol-mediated  	resveratrol-mediated  	 JJ	B-NP
endothelial  	endothelial  	 JJ	I-NP
shape  	shape  	 NN	I-NP
change 	change 	 NN	I-NP
.  	.  	 .	O
Our  	Our  	 PRP$	O
approach  	approach  	 NN	O
involved  	involved  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
selective  	selective  	 JJ	B-NP
inhibitors  	inhibitors  	 NN	I-NP
for  	for  	 IN	O
various  	various  	 JJ	O
signaling  	signaling  	 JJ	O
pathway 	pathway 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
studies  	studies  	 NNS	O
showed  	showed  	 VBD	O
that  	that  	 IN	O
quin2-AM  	quin2-AM  	 NNP	B-NP
( 	( 	 -LRB-	O
[ 	[ 	 -LRB-	O
Ca  	Ca  	 NNP	B-NP
2+ 	2+ 	 NNP	O
]  	]  	 -RRB-	O
inhibitor 	inhibitor 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
added  	added  	 VBD	O
together  	together  	 RB	O
with  	with  	 IN	O
resveratrol 	resveratrol 	 NN	B-NP
,  	,  	 ,	O
clearly  	clearly  	 RB	O
abolished  	abolished  	 VBN	O
the  	the  	 DT	O
endothelial  	endothelial  	 JJ	B-NP
cell  	cell  	 NN	I-NP
shape  	shape  	 NN	I-NP
change  	change  	 NN	I-NP
induced  	induced  	 NN	I-NP
by  	by  	 IN	O
the  	the  	 DT	O
polyphenol 	polyphenol 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
contrast 	contrast 	 NN	O
,  	,  	 ,	O
chelerythrine 	chelerythrine 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
PKC  	PKC  	 NNP	B-NP
inhibitor 	inhibitor 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
added  	added  	 VBD	O
alone  	alone  	 RB	O
triggered  	triggered  	 VBD	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
shape  	shape  	 NN	B-NP
change  	change  	 NN	I-NP
in  	in  	 IN	O
BPAEC 	BPAEC 	 NNP	B-NP
,  	,  	 ,	O
had  	had  	 VBD	O
no  	no  	 DT	O
effect  	effect  	 NN	O
on  	on  	 IN	O
resveratrol-elicited  	resveratrol-elicited  	 JJ	B-NP
morphological  	morphological  	 JJ	I-NP
change  	change  	 NN	I-NP
( 	( 	 -LRB-	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Analyzed  	Analyzed  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
whole 	whole 	 NN	O
,  	,  	 ,	O
these  	these  	 DT	O
experiments  	experiments  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
the  	the  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
cellular  	cellular  	 JJ	B-NP
phenotype 	phenotype 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 IN	O
a  	a  	 DT	O
consequence  	consequence  	 NN	O
of  	of  	 IN	O
resveratrol 	resveratrol 	 NNS	B-NP
: 	: 	 :	O
EC  	EC  	 NNP	B-NP
interaction 	interaction 	 NN	I-NP
,  	,  	 ,	O
is  	is  	 VBZ	O
dependent  	dependent  	 JJ	O
on  	on  	 IN	O
Ca  	Ca  	 NNP	B-NP
2+ 	2+ 	 NNP	O
,  	,  	 ,	O
tyrosine  	tyrosine  	 JJ	B-NP
kinases 	kinases 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
intact  	intact  	 JJ	O
actin  	actin  	 JJ	B-NP
microfilament  	microfilament  	 NN	I-NP
and  	and  	 CC	O
microtubules 	microtubules 	 NN	B-NP
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
also  	also  	 RB	O
raise  	raise  	 VB	O
the  	the  	 DT	O
possibility  	possibility  	 NN	O
that  	that  	 IN	O
there  	there  	 EX	O
is  	is  	 VBZ	O
cellular  	cellular  	 JJ	B-NP
heterogeneity  	heterogeneity  	 NN	I-NP
within  	within  	 IN	O
endothelial  	endothelial  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
used  	used  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
studies 	studies 	 NNS	O
,  	,  	 ,	O
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
fact  	fact  	 NN	O
that  	that  	 IN	O
a  	a  	 DT	O
subset  	subset  	 NN	B-NP
displayed  	displayed  	 VBD	O
exquisite  	exquisite  	 JJ	B-NP
sensitivity  	sensitivity  	 NN	I-NP
to  	to  	 TO	O
chelerythrine 	chelerythrine 	 VB	O
.  	.  	 .	O
Overall 	Overall 	 RB	O
,  	,  	 ,	O
these  	these  	 DT	O
results  	results  	 NNS	O
support  	support  	 VBP	O
the  	the  	 DT	O
notion  	notion  	 NN	O
that  	that  	 IN	O
resveratrol  	resveratrol  	 NN	B-NP
and  	and  	 CC	O
shear  	shear  	 JJ	O
stress  	stress  	 NN	O
induce  	induce  	 VB	O
elongation  	elongation  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
EC  	EC  	 NNP	B-NP
cytoskeleton  	cytoskeleton  	 NN	I-NP
via  	via  	 IN	O
an  	an  	 DT	O
overlapping  	overlapping  	 JJ	O
outside-in  	outside-in  	 JJ	O
signaling  	signaling  	 JJ	O
mechanism 	mechanism 	 NN	O
.  	.  	 .	O
Prolonged  	Prolonged  	 JJ	O
shear  	shear  	 NNS	O
stress  	stress  	 VBP	O
leading  	leading  	 VBG	O
to  	to  	 TO	O
mechanotransduction  	mechanotransduction  	 VB	O
signaling  	signaling  	 NN	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
activate  	activate  	 VB	O
the  	the  	 DT	O
MAP  	MAP  	 NNP	O
kinase  	kinase  	 VBD	O
pathway  	pathway  	 VBN	O
in  	in  	 IN	O
EC 	EC 	 NNP	B-NP
.  	.  	 .	O
Activation  	Activation  	 NNP	B-NP
of  	of  	 IN	I-NP
ERK1  	ERK1  	 NNP	I-NP
and  	and  	 CC	O
ERK2 	ERK2 	 NNP	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
major  	major  	 JJ	O
components  	components  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
MAPK  	MAPK  	 NNP	B-NP
pathway 	pathway 	 NN	I-NP
,  	,  	 ,	O
presumably  	presumably  	 RB	O
induces  	induces  	 VBZ	O
shear-specific  	shear-specific  	 JJ	B-NP
transcription  	transcription  	 JJ	I-NP
factors 	factors 	 NNS	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
c-fos 	c-fos 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
c-jun  	c-jun  	 NNP	I-NP
and  	and  	 CC	O
NFκB 	NFκB 	 JJ	O
,  	,  	 ,	O
ultimately  	ultimately  	 RB	O
leading  	leading  	 VBG	O
to  	to  	 TO	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
gene  	gene  	 NN	B-NP
expression  	expression  	 NN	I-NP
[  	[  	 -LRB-	O
30 	30 	 CD	O
,  	,  	 ,	O
31 	31 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Western  	Western  	 JJ	O
blot  	blot  	 JJ	O
analysis  	analysis  	 NN	O
of  	of  	 IN	O
control  	control  	 NN	O
and  	and  	 CC	O
25  	25  	 CD	O
μM  	μM  	 JJ	O
and  	and  	 CC	O
100  	100  	 CD	O
μM  	μM  	 JJ	B-NP
resveratrol-treated  	resveratrol-treated  	 JJ	I-NP
BPAEC  	BPAEC  	 NNP	I-NP
showed  	showed  	 VBD	O
that  	that  	 IN	O
there  	there  	 EX	O
was  	was  	 VBD	O
no  	no  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
active  	active  	 JJ	O
ERK  	ERK  	 NNP	B-NP
1 	1 	 CD	O
/ 	/ 	 CD	O
2  	2  	 CD	O
at  	at  	 IN	O
the  	the  	 DT	O
6  	6  	 CD	O
h  	h  	 NNS	O
and  	and  	 CC	O
2  	2  	 CD	O
day  	day  	 NN	O
time  	time  	 NN	O
points 	points 	 NNS	O
.  	.  	 .	O
Rather 	Rather 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
decline  	decline  	 NN	O
in  	in  	 IN	O
activated  	activated  	 JJ	O
ERK  	ERK  	 NNP	B-NP
1 	1 	 CD	O
/ 	/ 	 CD	O
2  	2  	 CD	O
seen  	seen  	 VBN	O
from  	from  	 IN	O
days  	days  	 NNS	O
2  	2  	 CD	O
to  	to  	 TO	O
4  	4  	 CD	O
of  	of  	 IN	O
control  	control  	 NN	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
was  	was  	 VBD	O
effectively  	effectively  	 RB	O
suppressed  	suppressed  	 VBN	O
by  	by  	 IN	O
resveratrol 	resveratrol 	 NN	B-NP
,  	,  	 ,	O
suggesting  	suggesting  	 VBG	O
that  	that  	 IN	O
the  	the  	 DT	O
polyphenol  	polyphenol  	 NN	B-NP
may  	may  	 MD	O
act  	act  	 VB	O
by  	by  	 IN	O
affecting  	affecting  	 VBG	O
the  	the  	 DT	O
stability  	stability  	 NN	O
of  	of  	 IN	O
active  	active  	 JJ	O
ERK1 	ERK1 	 CD	B-NP
/ 	/ 	 CD	O
2  	2  	 CD	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
6 	6 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
may  	may  	 MD	O
involve  	involve  	 VB	O
modulation  	modulation  	 VBN	O
of  	of  	 IN	O
MAPK  	MAPK  	 NNP	B-NP
phosphatase-1  	phosphatase-1  	 NNP	I-NP
( 	( 	 -LRB-	O
MKP-1 	MKP-1 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
a  	a  	 DT	O
member  	member  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
immediate-early  	immediate-early  	 JJ	B-NP
response  	response  	 NN	I-NP
gene  	gene  	 NN	I-NP
product  	product  	 NN	I-NP
functioning  	functioning  	 VBG	O
as  	as  	 IN	O
a  	a  	 DT	O
dual  	dual  	 JJ	B-NP
specificity  	specificity  	 JJ	I-NP
phosphase  	phosphase  	 NN	I-NP
to  	to  	 TO	O
reverse  	reverse  	 VB	O
MAPK  	MAPK  	 NNP	B-NP
[  	[  	 -LRB-	O
40 	40 	 CD	O
,  	,  	 ,	O
41 	41 	 CD	O
,  	,  	 ,	O
42 	42 	 CD	O
,  	,  	 ,	O
43 	43 	 CD	O
,  	,  	 ,	O
44 	44 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
by  	by  	 IN	O
resveratrol 	resveratrol 	 NN	B-NP
.  	.  	 .	O
Previously 	Previously 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
reported  	reported  	 VBN	O
that  	that  	 IN	O
MKP-1  	MKP-1  	 NNP	B-NP
is  	is  	 VBZ	O
rapidly  	rapidly  	 RB	O
induced  	induced  	 VBN	O
in  	in  	 IN	O
rat  	rat  	 FW	B-NP
carotid  	carotid  	 FW	I-NP
arterial  	arterial  	 FW	I-NP
wall  	wall  	 FW	I-NP
following  	following  	 FW	O
balloon  	balloon  	 FW	B-NP
catheter  	catheter  	 FW	I-NP
injury  	injury  	 FW	I-NP
[  	[  	 -LRB-	O
45 	45 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Since  	Since  	 IN	O
no  	no  	 DT	O
noticeable  	noticeable  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
active  	active  	 JJ	O
ERK1 	ERK1 	 CD	B-NP
/ 	/ 	 CD	O
2  	2  	 CD	O
occurred  	occurred  	 VBD	O
at  	at  	 IN	O
the  	the  	 DT	O
6  	6  	 CD	O
h  	h  	 NNS	O
or  	or  	 CC	O
2  	2  	 CD	O
day  	day  	 NN	O
time  	time  	 NN	O
points 	points 	 NNS	O
,  	,  	 ,	O
where  	where  	 WRB	O
morphological  	morphological  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
clearly  	clearly  	 RB	O
became  	became  	 VBD	O
visible 	visible 	 JJ	O
,  	,  	 ,	O
following  	following  	 VBG	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
resveratrol 	resveratrol 	 NN	B-NP
,  	,  	 ,	O
it  	it  	 PRP	O
seems  	seems  	 VBZ	O
unlikely  	unlikely  	 JJ	O
that  	that  	 IN	O
the  	the  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
MAPK  	MAPK  	 NNP	I-NP
is  	is  	 VBZ	O
directly  	directly  	 RB	O
linked  	linked  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
observed  	observed  	 JJ	O
morphologic  	morphologic  	 JJ	B-NP
changes 	changes 	 NNS	I-NP
.  	.  	 .	O
Responses  	Responses  	 NNS	O
of  	of  	 IN	O
cultured  	cultured  	 JJ	O
endothelial  	endothelial  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
to  	to  	 TO	O
arterial  	arterial  	 VB	O
shear  	shear  	 NNS	O
stress  	stress  	 VBP	O
Another  	Another  	 DT	O
significant  	significant  	 JJ	O
contribution  	contribution  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
research  	research  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
demonstration  	demonstration  	 NN	B-NP
that  	that  	 WDT	O
resveratrol  	resveratrol  	 VBZ	O
promoted  	promoted  	 VBN	O
a  	a  	 DT	O
greater  	greater  	 JJR	O
adherence  	adherence  	 NN	O
of  	of  	 IN	O
BPAEC  	BPAEC  	 NNP	B-NP
to  	to  	 TO	O
the  	the  	 DT	O
cultured  	cultured  	 JJ	O
vehicle  	vehicle  	 NN	B-NP
in  	in  	 IN	O
vitro  	vitro  	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
vivo  	vivo  	 NN	B-NP
,  	,  	 ,	O
such  	such  	 PDT	O
a  	a  	 DT	O
cellular  	cellular  	 JJ	B-NP
property  	property  	 NN	I-NP
could  	could  	 MD	O
make  	make  	 VB	O
endothelial  	endothelial  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
less  	less  	 RBR	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
dislodge  	dislodge  	 VB	O
to  	to  	 TO	O
become  	become  	 VB	O
part  	part  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
growing  	growing  	 VBG	O
thrombotic  	thrombotic  	 JJ	B-NP
plug 	plug 	 NN	I-NP
.  	.  	 .	O
Restricted  	Restricted  	 JJ	B-NP
detachment  	detachment  	 NN	I-NP
could  	could  	 MD	O
also  	also  	 RB	O
imply  	imply  	 VB	O
that  	that  	 IN	O
there  	there  	 EX	O
is  	is  	 VBZ	O
less  	less  	 JJR	O
degeneration  	degeneration  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
endothelial  	endothelial  	 JJ	I-NP
cell  	cell  	 NN	I-NP
monolayer 	monolayer 	 NN	I-NP
,  	,  	 ,	O
which 	which 	 WDT	O
,  	,  	 ,	O
in  	in  	 IN	O
turn 	turn 	 NN	O
,  	,  	 ,	O
would  	would  	 MD	O
reduce  	reduce  	 VB	O
the  	the  	 DT	O
exposure  	exposure  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
underlying  	underlying  	 JJ	O
subendothelial  	subendothelial  	 JJ	B-NP
matrix  	matrix  	 JJ	I-NP
components 	components 	 NNS	I-NP
,  	,  	 ,	O
thereby  	thereby  	 RB	O
making  	making  	 VBG	O
platelet  	platelet  	 JJ	B-NP
adhesion  	adhesion  	 NN	I-NP
and  	and  	 CC	O
aggregation  	aggregation  	 NN	B-NP
less  	less  	 RBR	O
likely 	likely 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
mechanism 	mechanism 	 NN	B-NP
( 	( 	 -LRB-	I-NP
s 	s 	 LS	I-NP
)  	)  	 -RRB-	I-NP
responsible  	responsible  	 JJ	O
for  	for  	 IN	O
the  	the  	 DT	O
resveratrol-induced  	resveratrol-induced  	 JJ	B-NP
cellular  	cellular  	 JJ	I-NP
properties  	properties  	 NNS	I-NP
remain  	remain  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
further  	further  	 RB	O
investigated 	investigated 	 VBN	O
.  	.  	 .	O
One  	One  	 CD	O
possibility  	possibility  	 NN	O
centers  	centers  	 NNS	O
on  	on  	 IN	O
modulation  	modulation  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
focal  	focal  	 JJ	B-NP
contact  	contact  	 NN	I-NP
adhesion  	adhesion  	 NN	I-NP
sites 	sites 	 NNS	I-NP
,  	,  	 ,	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
the  	the  	 DT	O
effective  	effective  	 JJ	O
redistribution  	redistribution  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
focal  	focal  	 JJ	I-NP
contacts 	contacts 	 NNS	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
the  	the  	 DT	O
increased  	increased  	 JJ	O
production  	production  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
EC-specific  	EC-specific  	 JJ	B-NP
integrin  	integrin  	 JJ	I-NP
complex 	complex 	 NN	I-NP
,  	,  	 ,	O
by  	by  	 IN	O
resveratrol 	resveratrol 	 NN	B-NP
,  	,  	 ,	O
all  	all  	 DT	O
of  	of  	 IN	O
which  	which  	 WDT	O
could  	could  	 MD	O
contribute  	contribute  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
cardioprotective  	cardioprotective  	 JJ	B-NP
mechanism  	mechanism  	 NN	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
polyphenol 	polyphenol 	 NN	B-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
should  	should  	 MD	O
be  	be  	 VB	O
emphasized  	emphasized  	 VBN	O
that  	that  	 IN	O
these  	these  	 DT	O
experiments  	experiments  	 NNS	O
involved  	involved  	 VBN	O
growing  	growing  	 VBG	B-NP
EC  	EC  	 NNP	I-NP
on  	on  	 IN	O
plastic 	plastic 	 NN	O
,  	,  	 ,	O
not  	not  	 RB	O
on  	on  	 IN	O
layers  	layers  	 NNS	O
of  	of  	 IN	O
subendothelial  	subendothelial  	 JJ	B-NP
matrix  	matrix  	 JJ	I-NP
components  	components  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
collagen  	collagen  	 NN	B-NP
or  	or  	 CC	O
fibrinogen 	fibrinogen 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
latter  	latter  	 JJ	O
experimental  	experimental  	 JJ	B-NP
format  	format  	 NN	I-NP
simulating  	simulating  	 VBD	O
a  	a  	 DT	O
more  	more  	 RBR	O
physiologically  	physiologically  	 JJ	B-NP
relevant  	relevant  	 JJ	I-NP
subendothelial  	subendothelial  	 JJ	I-NP
matrices  	matrices  	 NN	I-NP
may  	may  	 MD	O
yield  	yield  	 VB	O
vastly  	vastly  	 RB	O
different  	different  	 JJ	O
results 	results 	 NNS	O
.  	.  	 .	O
These  	These  	 DT	O
possibilities  	possibilities  	 NNS	O
warrant  	warrant  	 VBP	O
further  	further  	 JJ	O
investigation 	investigation 	 NN	B-NP
.  	.  	 .	O
Induction  	Induction  	 NNP	B-NP
of  	of  	 IN	I-NP
eNOS  	eNOS  	 JJ	I-NP
and  	and  	 CC	O
modulation  	modulation  	 NN	B-NP
of  	of  	 IN	I-NP
EC  	EC  	 NNP	I-NP
growth  	growth  	 NN	I-NP
by  	by  	 IN	O
resveratrol  	resveratrol  	 VBG	O
The  	The  	 DT	O
endothelial  	endothelial  	 JJ	B-NP
cell  	cell  	 NN	I-NP
lining  	lining  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
blood  	blood  	 NN	O
vessel  	vessel  	 NN	O
is  	is  	 VBZ	O
extremely  	extremely  	 RB	O
sensitive  	sensitive  	 JJ	O
to  	to  	 TO	O
damage  	damage  	 NN	O
from  	from  	 IN	O
reactive  	reactive  	 JJ	B-NP
oxygen  	oxygen  	 NN	I-NP
species  	species  	 NNS	I-NP
( 	( 	 -LRB-	O
ROS 	ROS 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
results  	results  	 NNS	O
of  	of  	 IN	O
which  	which  	 WDT	O
are  	are  	 VBP	O
losses  	losses  	 NNS	O
of  	of  	 IN	O
both  	both  	 DT	O
microvascular  	microvascular  	 JJ	B-NP
metabolic  	metabolic  	 JJ	I-NP
function  	function  	 NN	I-NP
and  	and  	 CC	O
barrier  	barrier  	 NN	B-NP
properties  	properties  	 NNS	I-NP
[  	[  	 -LRB-	O
46 	46 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
To  	To  	 TO	O
minimize  	minimize  	 VB	O
such  	such  	 JJ	O
oxidant  	oxidant  	 JJ	B-NP
damage 	damage 	 NN	I-NP
,  	,  	 ,	O
cells  	cells  	 NNS	O
rely  	rely  	 VBP	O
on  	on  	 IN	O
the  	the  	 DT	O
production  	production  	 NN	O
of  	of  	 IN	O
nitric  	nitric  	 JJ	B-NP
oxide  	oxide  	 NN	I-NP
( 	( 	 -LRB-	O
NO 	NO 	 UH	B-NP
)  	)  	 -RRB-	O
by  	by  	 IN	O
the  	the  	 DT	O
enzyme  	enzyme  	 FW	B-NP
nitric  	nitric  	 FW	I-NP
oxide  	oxide  	 FW	I-NP
synthase  	synthase  	 FW	I-NP
( 	( 	 -LRB-	O
eNOS 	eNOS 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Biological  	Biological  	 JJ	B-NP
functions  	functions  	 NNS	I-NP
attributed  	attributed  	 VBD	O
to  	to  	 TO	O
NO  	NO  	 RB	O
include  	include  	 VB	O
vasodilation  	vasodilation  	 NNS	B-NP
[  	[  	 -LRB-	O
47 	47 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
inhibition  	inhibition  	 VBG	O
of  	of  	 IN	O
platelet  	platelet  	 JJ	B-NP
adhesion  	adhesion  	 NN	I-NP
and  	and  	 CC	O
aggregation  	aggregation  	 NNS	B-NP
[  	[  	 -LRB-	O
48 	48 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
reduction  	reduction  	 NN	O
of  	of  	 IN	O
expression  	expression  	 NN	O
of  	of  	 IN	O
adhesion  	adhesion  	 JJ	B-NP
molecules  	molecules  	 NNS	I-NP
and  	and  	 CC	O
chemokines  	chemokines  	 NNS	B-NP
[  	[  	 -LRB-	O
49 	49 	 CD	O
,  	,  	 ,	O
50 	50 	 CD	O
,  	,  	 ,	O
51 	51 	 CD	O
,  	,  	 ,	O
52 	52 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
suppression  	suppression  	 NN	O
of  	of  	 IN	O
cell  	cell  	 NN	B-NP
growth  	growth  	 NN	I-NP
and  	and  	 CC	O
migration  	migration  	 NNS	O
[  	[  	 -LRB-	O
53 	53 	 CD	O
,  	,  	 ,	O
54 	54 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Therefore 	Therefore 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
investigated  	investigated  	 VBD	O
whether  	whether  	 IN	O
resveratrol  	resveratrol  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
could  	could  	 MD	O
lead  	lead  	 VB	O
to  	to  	 TO	O
increased  	increased  	 VB	B-NP
eNOS  	eNOS  	 JJ	I-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
endothelial  	endothelial  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
determined  	determined  	 VBD	O
that  	that  	 DT	O
resveratrol  	resveratrol  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
did  	did  	 VBD	O
induce  	induce  	 VB	O
eNOS  	eNOS  	 JJ	B-NP
expression  	expression  	 NN	I-NP
at  	at  	 IN	O
all  	all  	 DT	O
time  	time  	 NN	B-NP
points  	points  	 NNS	I-NP
tested  	tested  	 VBD	O
( 	( 	 -LRB-	O
6  	6  	 CD	O
h 	h 	 NN	O
,  	,  	 ,	O
2  	2  	 CD	O
days 	days 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
4  	4  	 CD	O
days 	days 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
agreed  	agreed  	 VBD	O
with  	with  	 IN	O
a  	a  	 DT	O
previous  	previous  	 JJ	O
report  	report  	 NN	O
from  	from  	 IN	O
this  	this  	 DT	O
laboratory  	laboratory  	 NN	O
[  	[  	 -LRB-	O
21 	21 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
peak  	peak  	 NN	B-NP
expression  	expression  	 NN	I-NP
of  	of  	 IN	I-NP
eNOS  	eNOS  	 NNP	I-NP
occurred  	occurred  	 VBD	O
at  	at  	 IN	O
2  	2  	 CD	O
days  	days  	 NNS	O
in  	in  	 IN	O
100  	100  	 CD	O
μM  	μM  	 JJ	B-NP
resveratrol-treated  	resveratrol-treated  	 JJ	I-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
These  	These  	 DT	O
findings  	findings  	 NNS	O
could  	could  	 MD	O
mean  	mean  	 VB	B-NP
that  	that  	 DT	O
dietary  	dietary  	 JJ	B-NP
resveratrol  	resveratrol  	 NN	I-NP
is  	is  	 VBZ	O
capable  	capable  	 JJ	O
of  	of  	 IN	O
providing  	providing  	 VBG	O
a  	a  	 DT	O
gradual  	gradual  	 JJ	O
yet  	yet  	 RB	O
sustained  	sustained  	 VBN	B-NP
increase  	increase  	 NN	I-NP
in  	in  	 IN	O
NO 	NO 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	O
resveratrol  	resveratrol  	 VBG	O
to  	to  	 TO	O
induce  	induce  	 VB	O
S 	S 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
G  	G  	 NNP	I-NP
2  	2  	 CD	O
growth  	growth  	 NN	B-NP
arrest  	arrest  	 NN	I-NP
[  	[  	 -LRB-	O
20 	20 	 CD	O
,  	,  	 ,	O
21 	21 	 CD	O
]  	]  	 -RRB-	O
suggests  	suggests  	 VBZ	O
an  	an  	 DT	O
additional  	additional  	 JJ	O
mechanism  	mechanism  	 NN	O
for  	for  	 IN	O
cells  	cells  	 NNS	O
to  	to  	 TO	O
rapidly  	rapidly  	 RB	O
and  	and  	 CC	O
efficiently  	efficiently  	 RB	O
repair  	repair  	 VB	O
any  	any  	 DT	O
endothelial  	endothelial  	 JJ	B-NP
cell  	cell  	 NN	I-NP
damage 	damage 	 NN	I-NP
.  	.  	 .	O
Overall 	Overall 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
collective  	collective  	 JJ	B-NP
effect  	effect  	 NN	I-NP
of  	of  	 IN	I-NP
resveratrol  	resveratrol  	 NNS	I-NP
would  	would  	 MD	O
be  	be  	 VB	O
to  	to  	 TO	O
decrease  	decrease  	 VB	O
endothelial  	endothelial  	 JJ	B-NP
injury  	injury  	 NN	I-NP
and  	and  	 CC	O
exposure  	exposure  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
subendothelial  	subendothelial  	 JJ	B-NP
matrix 	matrix 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
would  	would  	 MD	O
lessen  	lessen  	 VB	O
the  	the  	 DT	O
probability  	probability  	 NN	B-NP
of  	of  	 IN	O
formation  	formation  	 NN	O
of  	of  	 IN	O
atherosclerotic  	atherosclerotic  	 JJ	B-NP
plaques  	plaques  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
CHD  	CHD  	 NNP	B-NP
[  	[  	 -LRB-	O
53 	53 	 CD	O
,  	,  	 ,	O
54 	54 	 CD	O
,  	,  	 ,	O
55 	55 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Conclusions  	Conclusions  	 VBG	O
Our  	Our  	 PRP$	O
studies  	studies  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
resveratrol  	resveratrol  	 JJ	O
interacts  	interacts  	 NN	O
with  	with  	 IN	O
endothelial  	endothelial  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
in  	in  	 IN	O
vitro  	vitro  	 VBG	B-NP
to  	to  	 TO	O
elicit  	elicit  	 VB	O
morphological  	morphological  	 NNS	O
and  	and  	 CC	O
functional  	functional  	 JJ	B-NP
changes 	changes 	 NNS	I-NP
.  	.  	 .	O
Specifically 	Specifically 	 RB	O
,  	,  	 ,	O
resveratrol  	resveratrol  	 VBD	O
induced  	induced  	 VBN	O
an  	an  	 DT	O
elongated  	elongated  	 JJ	O
shape 	shape 	 NN	O
,  	,  	 ,	O
interspersed  	interspersed  	 VBN	O
with  	with  	 IN	O
long 	long 	 JJ	O
,  	,  	 ,	O
tortuous  	tortuous  	 JJ	B-NP
projections 	projections 	 NNS	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
cultured  	cultured  	 JJ	O
BPAEC 	BPAEC 	 NNP	B-NP
.  	.  	 .	O
Treated  	Treated  	 JJ	O
cells  	cells  	 NNS	O
resisted  	resisted  	 VBD	B-NP
detachment  	detachment  	 VBN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
plastic  	plastic  	 JJ	B-NP
coverslips  	coverslips  	 NN	I-NP
under  	under  	 IN	O
simulated  	simulated  	 JJ	O
arterial  	arterial  	 JJ	O
shear  	shear  	 JJ	O
stress  	stress  	 NN	B-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
These  	These  	 DT	O
results 	results 	 NNS	O
,  	,  	 ,	O
combined  	combined  	 VBN	O
with  	with  	 IN	O
data  	data  	 NNS	O
from  	from  	 IN	O
our  	our  	 PRP$	O
previous  	previous  	 JJ	O
studies 	studies 	 NNS	O
,  	,  	 ,	O
provide  	provide  	 VB	O
additional  	additional  	 JJ	O
support  	support  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
notion  	notion  	 NN	O
that  	that  	 IN	O
resveratrol  	resveratrol  	 JJ	B-NP
acts  	acts  	 NNS	I-NP
as  	as  	 IN	O
an  	an  	 DT	O
anti-atherosclerotic  	anti-atherosclerotic  	 JJ	B-NP
agent 	agent 	 NN	I-NP
.  	.  	 .	O
Whether  	Whether  	 IN	O
these  	these  	 DT	O
findings  	findings  	 NNS	O
can  	can  	 MD	O
be  	be  	 VB	O
extrapolated  	extrapolated  	 VBN	O
to  	to  	 TO	O
humans  	humans  	 NNS	O
require  	require  	 VBP	O
further  	further  	 JJ	O
study 	study 	 NN	O
.  	.  	 .	O
Materials  	Materials  	 NNS	O
and  	and  	 CC	O
Methods  	Methods  	 NNP	O
Cell  	Cell  	 NNP	O
culture  	culture  	 NN	O
and  	and  	 CC	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
resveratrol  	resveratrol  	 VBG	O
The  	The  	 DT	O
BPAEC  	BPAEC  	 NNP	B-NP
isolated  	isolated  	 VBD	O
from  	from  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
main  	main  	 JJ	I-NP
intrapulmonary  	intrapulmonary  	 JJ	I-NP
artery  	artery  	 NN	I-NP
of  	of  	 IN	O
calf  	calf  	 JJ	O
lungs  	lungs  	 NNS	O
were  	were  	 VBD	O
cultured  	cultured  	 VBN	O
in  	in  	 IN	O
minimal  	minimal  	 JJ	B-NP
essential  	essential  	 JJ	I-NP
medium  	medium  	 NN	I-NP
( 	( 	 -LRB-	O
MEM 	MEM 	 NNP	B-NP
)  	)  	 -RRB-	O
supplemented  	supplemented  	 NN	O
with  	with  	 IN	O
15 	15 	 CD	O
%  	%  	 NN	O
fetal  	fetal  	 JJ	B-NP
bovine  	bovine  	 JJ	I-NP
serum  	serum  	 NN	I-NP
and  	and  	 CC	O
containing  	containing  	 VBG	B-NP
D-valine  	D-valine  	 JJ	I-NP
as  	as  	 IN	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
[  	[  	 -LRB-	O
56 	56 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Plastic  	Plastic  	 JJ	B-NP
coverslips  	coverslips  	 NN	I-NP
on  	on  	 IN	O
which  	which  	 WDT	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
cultured  	cultured  	 RB	O
were  	were  	 VBD	O
sterilized  	sterilized  	 VBN	O
by  	by  	 IN	O
washing  	washing  	 VBG	O
in  	in  	 IN	O
ethanol 	ethanol 	 NN	B-NP
,  	,  	 ,	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
rinsing  	rinsing  	 CD	O
three  	three  	 CD	O
times  	times  	 NNS	O
in  	in  	 IN	O
MEM  	MEM  	 NNP	B-NP
and  	and  	 CC	O
15  	15  	 CD	O
min  	min  	 JJ	B-NP
exposure  	exposure  	 NN	I-NP
to  	to  	 TO	O
UV  	UV  	 NNP	B-NP
radiation 	radiation 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
coverslips  	coverslips  	 NN	B-NP
were  	were  	 VBD	O
placed  	placed  	 VBN	O
in  	in  	 IN	O
6-well  	6-well  	 CD	O
tissue  	tissue  	 NN	O
culture  	culture  	 NN	O
plates 	plates 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
2  	2  	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cells 	cells 	 NNS	O
,  	,  	 ,	O
at  	at  	 IN	O
an  	an  	 DT	O
initial  	initial  	 JJ	O
density  	density  	 NN	O
of  	of  	 IN	O
1  	1  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
5cells 	5cells 	 CD	O
/ 	/ 	 CD	O
ml 	ml 	 NN	O
,  	,  	 ,	O
were  	were  	 VBD	O
added  	added  	 VBN	O
to  	to  	 TO	O
each  	each  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
wells 	wells 	 NNS	O
.  	.  	 .	O
Twenty-four  	Twenty-four  	 CD	O
h  	h  	 NN	O
after  	after  	 IN	O
seeding 	seeding 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
coverslips  	coverslips  	 NN	B-NP
were  	were  	 VBD	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
0,10 	0,10 	 NNP	O
,  	,  	 ,	O
25 	25 	 CD	O
,  	,  	 ,	O
50 	50 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
100  	100  	 CD	O
μM  	μM  	 JJ	B-NP
resveratrol  	resveratrol  	 NN	I-NP
and  	and  	 CC	O
maintained  	maintained  	 VBN	O
for  	for  	 IN	O
2  	2  	 CD	O
days  	days  	 NNS	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
until  	until  	 IN	O
they  	they  	 PRP	O
were  	were  	 VBD	O
fixed  	fixed  	 VBN	O
and  	and  	 CC	O
stained  	stained  	 NN	O
for  	for  	 IN	O
confocal  	confocal  	 JJ	B-NP
microscopy 	microscopy 	 NN	I-NP
.  	.  	 .	O
Preparation  	Preparation  	 NN	B-NP
and  	and  	 CC	O
staining  	staining  	 NN	O
of  	of  	 IN	O
slides  	slides  	 FW	O
Coverslips  	Coverslips  	 FW	B-NP
containing  	containing  	 FW	O
adhered  	adhered  	 FW	B-NP
BPAEC  	BPAEC  	 NNP	I-NP
were  	were  	 VBD	O
washed  	washed  	 VBN	O
for  	for  	 IN	O
5  	5  	 CD	O
min  	min  	 NN	B-NP
in  	in  	 IN	O
TBS 	TBS 	 NNP	B-NP
,  	,  	 ,	O
fixed  	fixed  	 VBN	O
with  	with  	 IN	O
5 	5 	 CD	O
%  	%  	 NN	O
glutaraldehyde  	glutaraldehyde  	 NN	B-NP
in  	in  	 IN	O
0.1  	0.1  	 CD	O
M  	M  	 NNP	O
cacodylate  	cacodylate  	 NNS	B-NP
( 	( 	 -LRB-	O
pH  	pH  	 NNP	B-NP
7.4 	7.4 	 CD	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
15  	15  	 CD	O
min 	min 	 NN	B-NP
,  	,  	 ,	O
washed  	washed  	 VBD	O
again  	again  	 RB	O
for  	for  	 IN	O
5  	5  	 CD	O
min  	min  	 NN	B-NP
in  	in  	 IN	O
TBS 	TBS 	 NNP	B-NP
,  	,  	 ,	O
then  	then  	 RB	O
stored  	stored  	 VBN	O
in  	in  	 IN	O
0.1  	0.1  	 CD	O
M  	M  	 NNP	O
cacodylate 	cacodylate 	 VBD	O
/ 	/ 	 CD	O
7 	7 	 CD	O
%  	%  	 NN	O
sucrose  	sucrose  	 NN	B-NP
at  	at  	 IN	O
4°C  	4°C  	 CD	O
until  	until  	 IN	O
staining 	staining 	 NN	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
permeabilized  	permeabilized  	 VBN	O
with  	with  	 IN	O
0.1 	0.1 	 CD	O
%  	%  	 NN	O
Triton  	Triton  	 NNP	B-NP
X-100 	X-100 	 NNP	I-NP
/ 	/ 	 NNP	O
TBS  	TBS  	 NNP	B-NP
for  	for  	 IN	O
3  	3  	 CD	O
min 	min 	 NN	B-NP
,  	,  	 ,	O
washed  	washed  	 VBD	O
twice  	twice  	 RB	O
with  	with  	 IN	O
TBS 	TBS 	 NNP	B-NP
,  	,  	 ,	O
blocked  	blocked  	 VBD	O
twice  	twice  	 RB	O
for  	for  	 IN	O
3  	3  	 CD	O
min  	min  	 NN	B-NP
with  	with  	 IN	O
0.1 	0.1 	 CD	O
%  	%  	 NN	O
bovine  	bovine  	 NNS	B-NP
serum  	serum  	 VBP	I-NP
albumin  	albumin  	 VBN	O
in  	in  	 IN	O
TBS 	TBS 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
incubated  	incubated  	 NN	O
with  	with  	 IN	O
rhodamine-conjugated  	rhodamine-conjugated  	 JJ	B-NP
phalloidin  	phalloidin  	 NN	I-NP
for  	for  	 IN	O
20  	20  	 CD	O
min 	min 	 NNS	B-NP
.  	.  	 .	O
Routinely 	Routinely 	 RB	O
,  	,  	 ,	O
5  	5  	 CD	O
μl  	μl  	 NN	B-NP
of  	of  	 IN	I-NP
rhodamine-phalloidin 	rhodamine-phalloidin 	 NNP	I-NP
,  	,  	 ,	O
dissolved  	dissolved  	 VBN	O
in  	in  	 IN	O
200  	200  	 CD	O
μl  	μl  	 JJ	B-NP
TBS 	TBS 	 NNP	I-NP
,  	,  	 ,	O
was  	was  	 VBD	O
used  	used  	 VBN	O
for  	for  	 IN	O
each  	each  	 DT	O
coverslip  	coverslip  	 JJ	B-NP
stained 	stained 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
coverslips  	coverslips  	 NN	B-NP
were  	were  	 VBD	O
wash  	wash  	 VBN	O
with  	with  	 IN	O
0.1 	0.1 	 CD	O
%  	%  	 NN	O
BSA 	BSA 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
TBS  	TBS  	 NNP	I-NP
for  	for  	 IN	O
3  	3  	 CD	O
min 	min 	 NN	B-NP
,  	,  	 ,	O
then  	then  	 RB	O
mounted  	mounted  	 VBN	O
in  	in  	 IN	O
an  	an  	 DT	O
inverted  	inverted  	 JJ	O
position  	position  	 NN	O
onto  	onto  	 IN	O
TBS-containing  	TBS-containing  	 JJ	O
beveled  	beveled  	 JJ	O
glass  	glass  	 NN	O
slides  	slides  	 NNS	O
and  	and  	 CC	O
sealed  	sealed  	 VBN	O
with  	with  	 IN	O
clear  	clear  	 JJ	O
nail  	nail  	 NN	O
polish 	polish 	 NN	O
.  	.  	 .	O
Perfusion  	Perfusion  	 VBG	O
A  	A  	 DT	O
parallel  	parallel  	 JJ	B-NP
plate  	plate  	 NN	I-NP
perfusion  	perfusion  	 NN	I-NP
chamber  	chamber  	 NN	I-NP
as  	as  	 IN	O
described  	described  	 VBN	O
previously  	previously  	 RB	O
[  	[  	 -LRB-	O
57 	57 	 CD	O
]  	]  	 -RRB-	O
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
generate  	generate  	 VB	O
simulated  	simulated  	 JJ	O
arterial  	arterial  	 JJ	B-NP
flow  	flow  	 NN	I-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
chamber  	chamber  	 NN	O
consisted  	consisted  	 VBD	O
of  	of  	 IN	O
three  	three  	 CD	O
pieces 	pieces 	 NNS	O
:  	:  	 :	O
two  	two  	 CD	O
rectangular  	rectangular  	 CD	B-NP
slabs  	slabs  	 NNS	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
central  	central  	 JJ	O
knob  	knob  	 NN	B-NP
with  	with  	 IN	O
a  	a  	 DT	O
depression  	depression  	 NN	O
that  	that  	 WDT	O
fits  	fits  	 VBZ	O
18  	18  	 CD	O
by  	by  	 IN	O
21  	21  	 CD	O
mm  	mm  	 CD	B-NP
coverslips 	coverslips 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
depression  	depression  	 NN	O
containing  	containing  	 VBG	O
the  	the  	 DT	O
coverslip  	coverslip  	 NN	B-NP
was  	was  	 VBD	O
placed  	placed  	 VBN	O
perpendicularly  	perpendicularly  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
flow  	flow  	 NN	O
of  	of  	 IN	O
perfusate 	perfusate 	 NN	B-NP
.  	.  	 .	O
A  	A  	 DT	O
laminar  	laminar  	 JJ	B-NP
arterial  	arterial  	 JJ	I-NP
shear  	shear  	 JJ	O
rate  	rate  	 NN	O
of  	of  	 IN	O
650  	650  	 CD	O
s  	s  	 NNS	O
-1was  	-1was  	 VBP	O
achieved  	achieved  	 VBN	O
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
dimensions  	dimensions  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
flow  	flow  	 NN	B-NP
chamber  	chamber  	 NN	I-NP
slit  	slit  	 NNS	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
constant  	constant  	 JJ	O
flow  	flow  	 NN	B-NP
rate  	rate  	 NN	I-NP
of  	of  	 IN	O
10  	10  	 CD	O
ml 	ml 	 CD	B-NP
/ 	/ 	 CD	I-NP
min 	min 	 NNS	I-NP
.  	.  	 .	O
After  	After  	 IN	O
preincubation  	preincubation  	 NN	B-NP
at  	at  	 IN	O
37°C 	37°C 	 NNP	O
,  	,  	 ,	O
minimal  	minimal  	 JJ	O
medium  	medium  	 NN	O
was  	was  	 VBD	O
drawn  	drawn  	 VBN	O
directly  	directly  	 RB	O
by  	by  	 IN	O
an  	an  	 DT	O
eight  	eight  	 CD	O
roller  	roller  	 NN	B-NP
peristaltic  	peristaltic  	 NNS	I-NP
pump  	pump  	 VBP	O
through  	through  	 IN	O
the  	the  	 DT	O
perfusion  	perfusion  	 JJ	B-NP
chamber  	chamber  	 NN	I-NP
containing  	containing  	 VBG	O
the  	the  	 DT	O
BPAEC-covered  	BPAEC-covered  	 JJ	B-NP
coverslip  	coverslip  	 NN	I-NP
positioned  	positioned  	 VBD	O
70  	70  	 CD	O
mm  	mm  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
inlet  	inlet  	 JJ	B-NP
valve  	valve  	 NN	I-NP
at  	at  	 IN	O
a  	a  	 DT	O
rate  	rate  	 NN	O
of  	of  	 IN	O
10  	10  	 CD	O
ml 	ml 	 CD	B-NP
/ 	/ 	 CD	I-NP
min  	min  	 NN	I-NP
for  	for  	 IN	O
either  	either  	 DT	O
2  	2  	 CD	O
min  	min  	 NNS	B-NP
or  	or  	 CC	O
5  	5  	 CD	O
min 	min 	 NNS	B-NP
.  	.  	 .	O
A  	A  	 DT	O
recirculating  	recirculating  	 JJ	B-NP
system  	system  	 NN	I-NP
was  	was  	 VBD	O
employed  	employed  	 VBN	O
to  	to  	 TO	O
recycle  	recycle  	 VB	O
the  	the  	 DT	O
medium  	medium  	 NN	O
after  	after  	 IN	O
passing  	passing  	 VBG	O
through  	through  	 IN	O
the  	the  	 DT	O
chamber 	chamber 	 NN	O
.  	.  	 .	O
Confocal  	Confocal  	 FW	B-NP
microscopy  	microscopy  	 FW	I-NP
Prepared  	Prepared  	 FW	I-NP
slides  	slides  	 FW	I-NP
containing  	containing  	 FW	O
adhered  	adhered  	 FW	B-NP
BPAEC  	BPAEC  	 NNP	I-NP
were  	were  	 VBD	O
examined  	examined  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
BioRad  	BioRad  	 JJ	B-NP
confocal  	confocal  	 JJ	I-NP
microscope 	microscope 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
imaged  	imaged  	 VBN	O
following  	following  	 VBG	O
excitation  	excitation  	 NN	B-NP
of  	of  	 IN	I-NP
rhodamine-phalloidin  	rhodamine-phalloidin  	 JJ	I-NP
with  	with  	 IN	O
an  	an  	 DT	O
argon  	argon  	 JJ	O
laser  	laser  	 NN	O
beam  	beam  	 NN	O
at  	at  	 IN	O
a  	a  	 DT	O
wavelength  	wavelength  	 NN	O
of  	of  	 IN	O
554  	554  	 CD	O
nm  	nm  	 NNS	B-NP
using  	using  	 VBG	O
either  	either  	 RB	O
an  	an  	 DT	O
inverted-  	inverted-  	 JJ	O
or  	or  	 CC	O
an  	an  	 DT	O
uprighted-staged  	uprighted-staged  	 JJ	B-NP
microscope  	microscope  	 NN	I-NP
equipped  	equipped  	 VBN	O
with  	with  	 IN	O
either  	either  	 RB	O
a  	a  	 DT	O
10X  	10X  	 NNP	O
or  	or  	 CC	O
a  	a  	 DT	O
20X  	20X  	 JJ	O
oil-free  	oil-free  	 JJ	O
objective  	objective  	 NN	O
and  	and  	 CC	O
an  	an  	 DT	O
epifluorescent  	epifluorescent  	 JJ	B-NP
illumination  	illumination  	 JJ	I-NP
attachment 	attachment 	 NN	I-NP
.  	.  	 .	O
Cells  	Cells  	 NNS	O
viewed  	viewed  	 VBN	O
in  	in  	 IN	O
representative  	representative  	 JJ	B-NP
field  	field  	 NN	I-NP
screen  	screen  	 NN	I-NP
captures  	captures  	 NNS	I-NP
were  	were  	 VBD	O
counted  	counted  	 VBN	O
manually  	manually  	 RB	O
for  	for  	 IN	O
cell  	cell  	 NN	O
morphology  	morphology  	 NNS	O
and  	and  	 CC	O
classified  	classified  	 VBN	O
as  	as  	 IN	O
either  	either  	 DT	O
normal  	normal  	 JJ	O
or  	or  	 CC	O
elongated 	elongated 	 NN	O
.  	.  	 .	O
Inhibitor  	Inhibitor  	 JJ	B-NP
study  	study  	 NN	I-NP
Passages  	Passages  	 NNP	I-NP
4-5  	4-5  	 NNP	O
BPAEC  	BPAEC  	 NNP	O
were  	were  	 VBD	O
seeded  	seeded  	 VBN	O
on  	on  	 IN	O
plastic  	plastic  	 JJ	B-NP
coverslips  	coverslips  	 NN	I-NP
as  	as  	 IN	O
described  	described  	 VBN	O
above 	above 	 IN	O
.  	.  	 .	O
Inhibitor  	Inhibitor  	 JJ	B-NP
concentrations  	concentrations  	 NNS	I-NP
were  	were  	 VBD	O
the  	the  	 DT	O
same  	same  	 JJ	O
as  	as  	 IN	O
in  	in  	 IN	O
[  	[  	 -LRB-	O
28 	28 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Stock  	Stock  	 NN	B-NP
solutions  	solutions  	 NNS	I-NP
were  	were  	 VBD	O
prepared  	prepared  	 VBN	O
by  	by  	 IN	O
dissolving  	dissolving  	 VBG	O
the  	the  	 DT	O
inhibitors  	inhibitors  	 NN	O
in  	in  	 IN	O
DMSO 	DMSO 	 NNP	B-NP
.  	.  	 .	O
The  	The  	 DT	O
inhibitors  	inhibitors  	 NN	O
used  	used  	 VBN	O
and  	and  	 CC	O
their  	their  	 PRP$	O
stock  	stock  	 NN	B-NP
solutions  	solutions  	 NNS	I-NP
were  	were  	 VBD	O
as  	as  	 RB	O
follows 	follows 	 VBZ	O
:  	:  	 :	O
quin2-AM  	quin2-AM  	 CD	B-NP
( 	( 	 -LRB-	O
Sigma 	Sigma 	 NNP	B-NP
,  	,  	 ,	O
2  	2  	 CD	O
mM 	mM 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
herbimycin  	herbimycin  	 VBG	O
A  	A  	 DT	O
( 	( 	 -LRB-	O
GibcoBRL 	GibcoBRL 	 NNP	B-NP
,  	,  	 ,	O
0.175  	0.175  	 NNP	O
mM 	mM 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
chelerythrine  	chelerythrine  	 NNS	B-NP
( 	( 	 -LRB-	O
Sigma 	Sigma 	 NNP	B-NP
,  	,  	 ,	O
0.4  	0.4  	 CD	O
mM 	mM 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
cytochalasin  	cytochalasin  	 VBG	O
D  	D  	 NNP	O
( 	( 	 -LRB-	O
Sigma 	Sigma 	 NNP	B-NP
,  	,  	 ,	O
8  	8  	 CD	O
μM 	μM 	 NN	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
nocodazole  	nocodazole  	 NNS	B-NP
( 	( 	 -LRB-	O
Sigma 	Sigma 	 NNP	B-NP
,  	,  	 ,	O
0.66  	0.66  	 NNP	O
mM 	mM 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Quin2-AM 	Quin2-AM 	 NNP	B-NP
,  	,  	 ,	O
herbimycin  	herbimycin  	 VBG	O
A 	A 	 DT	O
,  	,  	 ,	O
chelerythrine 	chelerythrine 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
cytochalasin  	cytochalasin  	 JJ	O
D  	D  	 NNP	O
were  	were  	 VBD	O
stored  	stored  	 VBN	O
at  	at  	 IN	O
-20°C 	-20°C 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
nocodazole  	nocodazole  	 NNS	B-NP
was  	was  	 VBD	O
stored  	stored  	 VBN	O
at  	at  	 IN	O
4°C 	4°C 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
stock  	stock  	 NN	B-NP
solutions  	solutions  	 NNS	I-NP
were  	were  	 VBD	O
diluted  	diluted  	 VBN	O
1 	1 	 CD	O
: 	: 	 :	O
200  	200  	 CD	O
in  	in  	 IN	O
MEM  	MEM  	 NNP	B-NP
to  	to  	 TO	O
give  	give  	 VB	O
the  	the  	 DT	O
following  	following  	 JJ	O
final  	final  	 JJ	B-NP
concentrations 	concentrations 	 NNS	I-NP
:  	:  	 :	O
quin2-AM  	quin2-AM  	 CD	B-NP
( 	( 	 -LRB-	O
10  	10  	 CD	O
μM 	μM 	 NN	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
herbimycin  	herbimycin  	 VBG	O
A  	A  	 DT	O
( 	( 	 -LRB-	O
875  	875  	 CD	O
nM 	nM 	 NN	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
chelerythrine  	chelerythrine  	 NNS	B-NP
( 	( 	 -LRB-	O
2  	2  	 CD	O
μM 	μM 	 NN	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
cytochalasin  	cytochalasin  	 VBG	O
D  	D  	 NNP	O
( 	( 	 -LRB-	O
40  	40  	 CD	O
nM 	nM 	 NN	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
nocodazole  	nocodazole  	 NNS	B-NP
( 	( 	 -LRB-	O
3.3  	3.3  	 CD	O
μM 	μM 	 NN	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Inhibitors  	Inhibitors  	 NNP	O
were  	were  	 VBD	O
applied  	applied  	 VBN	O
24  	24  	 CD	O
h  	h  	 NNS	B-NP
prior  	prior  	 RB	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
addition  	addition  	 NN	B-NP
of  	of  	 IN	I-NP
resveratrol 	resveratrol 	 NN	I-NP
,  	,  	 ,	O
except  	except  	 IN	O
for  	for  	 IN	O
quin2-AM 	quin2-AM 	 NNP	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
was  	was  	 VBD	O
applied  	applied  	 VBN	O
1  	1  	 CD	O
h  	h  	 NNS	B-NP
prior  	prior  	 RB	I-NP
to  	to  	 TO	O
resveratrol  	resveratrol  	 VB	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
Since  	Since  	 IN	O
cells  	cells  	 NNS	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
various  	various  	 JJ	O
inhibitors  	inhibitors  	 NN	O
grew  	grew  	 VBD	O
less  	less  	 RBR	O
well 	well 	 RB	O
,  	,  	 ,	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
controls 	controls 	 NNS	O
,  	,  	 ,	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
100  	100  	 CD	O
μM  	μM  	 JJ	B-NP
resveratrol  	resveratrol  	 NN	I-NP
was  	was  	 VBD	O
reduced  	reduced  	 VBN	O
to  	to  	 TO	O
approximately  	approximately  	 RB	O
40  	40  	 CD	O
h 	h 	 NNS	O
.  	.  	 .	O
Fixing  	Fixing  	 NNP	O
and  	and  	 CC	O
staining  	staining  	 NN	O
of  	of  	 IN	O
cells  	cells  	 NNS	O
for  	for  	 IN	O
confocal  	confocal  	 JJ	B-NP
microscopy  	microscopy  	 NN	I-NP
was  	was  	 VBD	O
as  	as  	 RB	O
described  	described  	 VBN	O
above 	above 	 IN	O
.  	.  	 .	O
Western  	Western  	 JJ	O
blot  	blot  	 JJ	O
analysis  	analysis  	 NN	O
Control  	Control  	 NNP	O
and  	and  	 CC	O
treated  	treated  	 JJ	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
lysed  	lysed  	 VBN	O
by  	by  	 IN	O
repeated  	repeated  	 VBN	B-NP
freeze-thaw  	freeze-thaw  	 JJ	I-NP
cycles  	cycles  	 NNS	I-NP
with  	with  	 IN	O
buffer  	buffer  	 NN	B-NP
containing  	containing  	 VBG	O
10  	10  	 CD	O
mM  	mM  	 JJ	B-NP
HEPES  	HEPES  	 NNP	I-NP
( 	( 	 -LRB-	O
pH  	pH  	 NNP	B-NP
7.5 	7.5 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
1.5  	1.5  	 CD	O
mM  	mM  	 JJ	B-NP
Mg 	Mg 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
OAc 	OAc 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
2  	2  	 CD	O
,  	,  	 ,	O
1  	1  	 CD	O
mM  	mM  	 JJ	B-NP
dithiothreitol  	dithiothreitol  	 NNS	I-NP
( 	( 	 -LRB-	O
DTT 	DTT 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
0.5 	0.5 	 CD	O
%  	%  	 NN	O
NP40 	NP40 	 NN	B-NP
,  	,  	 ,	O
5 	5 	 CD	O
%  	%  	 NN	O
glycerol 	glycerol 	 NN	B-NP
,  	,  	 ,	O
0.5  	0.5  	 CD	O
mM  	mM  	 JJ	O
phenylmethylsulfonyl  	phenylmethylsulfonyl  	 JJ	B-NP
fluoride 	fluoride 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
10  	10  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml  	ml  	 CD	I-NP
each  	each  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
protease  	protease  	 JJ	B-NP
inhibitors  	inhibitors  	 JJ	I-NP
aprotinin 	aprotinin 	 NN	I-NP
,  	,  	 ,	O
pepstatin 	pepstatin 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
leupeptin 	leupeptin 	 NN	B-NP
.  	.  	 .	O
Cell-free  	Cell-free  	 JJ	B-NP
extracts  	extracts  	 NN	I-NP
were  	were  	 VBD	O
obtained  	obtained  	 VBN	O
by  	by  	 IN	O
centrifugation  	centrifugation  	 NN	B-NP
in  	in  	 IN	O
a  	a  	 DT	O
microcentrifuge 	microcentrifuge 	 NN	B-NP
.  	.  	 .	O
Lysates  	Lysates  	 NNP	B-NP
( 	( 	 -LRB-	O
7-10  	7-10  	 FW	O
μg 	μg 	 FW	B-NP
)  	)  	 -RRB-	O
from  	from  	 IN	O
control  	control  	 NN	O
and  	and  	 CC	O
treated  	treated  	 JJ	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
separated  	separated  	 VBN	O
on  	on  	 IN	O
10 	10 	 CD	O
%  	%  	 NN	O
SDS-PAGE 	SDS-PAGE 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
separated  	separated  	 JJ	O
proteins  	proteins  	 NNS	O
were  	were  	 VBD	O
transferred  	transferred  	 VBN	O
to  	to  	 TO	O
nitrocellulose  	nitrocellulose  	 VB	O
membranes 	membranes 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
membranes  	membranes  	 NN	O
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
respective  	respective  	 JJ	O
primary  	primary  	 JJ	O
and  	and  	 CC	O
secondary  	secondary  	 JJ	B-NP
antibodies 	antibodies 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
monoclonal  	monoclonal  	 JJ	B-NP
primary  	primary  	 JJ	I-NP
antibodies  	antibodies  	 NNS	I-NP
used  	used  	 VBN	O
and  	and  	 CC	O
their  	their  	 PRP$	O
dilutions  	dilutions  	 NN	O
were  	were  	 VBD	O
as  	as  	 RB	O
follows 	follows 	 VBZ	O
:  	:  	 :	O
Phosphorylated 	Phosphorylated 	 NNP	O
,  	,  	 ,	O
active  	active  	 JJ	O
ERK1 	ERK1 	 CD	B-NP
/ 	/ 	 CD	O
2-P  	2-P  	 CD	B-NP
( 	( 	 -LRB-	O
RBI 	RBI 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Sigma 	Sigma 	 NNP	I-NP
,  	,  	 ,	O
1 	1 	 CD	O
: 	: 	 :	O
1000 	1000 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
total  	total  	 JJ	B-NP
ERK1 	ERK1 	 CD	I-NP
/ 	/ 	 CD	O
2  	2  	 CD	O
( 	( 	 -LRB-	O
RBI 	RBI 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Sigma 	Sigma 	 NNP	I-NP
,  	,  	 ,	O
1 	1 	 CD	O
: 	: 	 :	O
1000 	1000 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
eIF4E  	eIF4E  	 NNP	O
( 	( 	 -LRB-	O
Santa  	Santa  	 NNP	O
Cruz 	Cruz 	 NNP	O
,  	,  	 ,	O
1 	1 	 CD	O
: 	: 	 :	O
250 	250 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
eNOS  	eNOS  	 NNP	B-NP
( 	( 	 -LRB-	O
Sigma  	Sigma  	 NNP	B-NP
1 	1 	 CD	O
: 	: 	 :	O
1000 	1000 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Membranes  	Membranes  	 NNP	O
were  	were  	 VBD	O
probed  	probed  	 VBN	O
with  	with  	 IN	O
alkaline  	alkaline  	 JJ	B-NP
phosphatase-conjugated  	phosphatase-conjugated  	 JJ	I-NP
IgG  	IgG  	 NN	I-NP
( 	( 	 -LRB-	O
Santa  	Santa  	 NNP	O
Cruz 	Cruz 	 NNP	O
,  	,  	 ,	O
1 	1 	 CD	O
: 	: 	 :	O
1500 	1500 	 CD	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
horseradish  	horseradish  	 JJ	B-NP
peroxidase-conjugated  	peroxidase-conjugated  	 JJ	I-NP
IgG  	IgG  	 NN	I-NP
( 	( 	 -LRB-	O
Santa  	Santa  	 NNP	O
Cruz 	Cruz 	 NNP	O
,  	,  	 ,	O
1 	1 	 CD	O
: 	: 	 :	O
2000 	2000 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Specific  	Specific  	 JJ	B-NP
immunoreactive  	immunoreactive  	 JJ	I-NP
bands  	bands  	 NNS	I-NP
were  	were  	 VBD	O
identified  	identified  	 VBN	O
by  	by  	 IN	O
color  	color  	 NN	B-NP
reaction  	reaction  	 NN	I-NP
or  	or  	 CC	O
enhanced  	enhanced  	 JJ	O
chemiluminescence 	chemiluminescence 	 NN	B-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
